| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYO10 KIF11 DYNC2H1 MYO1H MYO19 KIF16B MYO18A DNAH7 SMC3 MYH14 DNAH17 KIF18B | 6.20e-08 | 118 | 267 | 12 | GO:0003774 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA1 MYO10 PEX6 ARID1A ABCC8 RECQL4 HELZ KIF11 PMS1 ABCC1 DYNC2H1 MYO1H MYO19 KIF16B MYO18A ABCC11 INO80 DNAH7 DDX27 ATP2C1 SMC3 MYH14 DNAH17 KIF18B ATP2A2 TP53 | 2.40e-07 | 614 | 267 | 26 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA1 PEX6 ABCC8 RECQL4 PMS1 ABCC1 DYNC2H1 MYO19 KIF16B MYO18A ABCC11 INO80 DNAH7 DDX27 ATP2C1 SMC3 KIF18B ATP2A2 | 2.97e-05 | 441 | 267 | 18 | GO:0016887 |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.13e-05 | 70 | 267 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.26e-04 | 37 | 267 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 1.28e-04 | 20 | 267 | 4 | GO:0061608 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 2.87e-04 | 95 | 267 | 7 | GO:0140767 | |
| GeneOntologyMolecularFunction | plus-end directed microfilament motor activity | 5.30e-04 | 3 | 267 | 2 | GO:0060002 | |
| GeneOntologyMolecularFunction | enzyme regulator activity | RPS6KA1 SRC RGPD1 WDR81 ADGRV1 ARHGEF11 WNK1 BIRC6 GTF3C4 KIDINS220 RASGRP3 RGPD3 DENND6B HERC2 DNMBP ALK RIC1 RASAL2 HTRA2 DOCK8 ITSN1 MADD PPP4R3A DNTTIP1 SLCO1B7 PPP4R3B ARHGAP6 PPP2R3A PPP2R5D NPRL3 PPP1R36 ARHGAP45 TP53 ARHGAP19 | 6.73e-04 | 1418 | 267 | 34 | GO:0030234 |
| GeneOntologyMolecularFunction | tubulin binding | DCDC1 CKAP5 NME8 ABRAXAS2 CCDC66 CCSER2 SPATA4 KIF11 DIP2B KIF16B INO80 SPAG6 SPAG5 SMC3 KIF18B | 6.87e-04 | 428 | 267 | 15 | GO:0015631 |
| GeneOntologyMolecularFunction | ubiquitin-like ligase-substrate adaptor activity | 8.09e-04 | 82 | 267 | 6 | GO:1990756 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYLK DCDC1 MYO10 CKAP5 SYNPO ADGRV1 NME8 PXK ABRAXAS2 SPTBN5 CCDC66 ANLN CCSER2 SPATA4 KIF11 DIP2B MYO1H MYO19 KIF16B MYO18A INO80 SPAG6 SPAG5 SMC3 MYH14 TNS4 KIF18B CROCC | 8.29e-04 | 1099 | 267 | 28 | GO:0008092 |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 8.30e-04 | 55 | 267 | 5 | GO:0042974 | |
| GeneOntologyMolecularFunction | nucleocytoplasmic carrier activity | 8.37e-04 | 32 | 267 | 4 | GO:0140142 | |
| GeneOntologyMolecularFunction | microtubule binding | DCDC1 CKAP5 NME8 ABRAXAS2 CCDC66 CCSER2 SPATA4 KIF11 KIF16B SPAG6 SPAG5 KIF18B | 9.51e-04 | 308 | 267 | 12 | GO:0008017 |
| GeneOntologyMolecularFunction | nuclear receptor binding | SRC PRAMEF1 ARID1A PRAMEF2 MED24 CCDC62 PRAMEF13 PRAMEF14 PRAME | 9.59e-04 | 187 | 267 | 9 | GO:0016922 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD1 ARHGEF11 RASGRP3 RGPD3 DENND6B HERC2 DNMBP RIC1 RASAL2 DOCK8 ITSN1 MADD ARHGAP6 NPRL3 ARHGAP45 ARHGAP19 | 1.39e-03 | 507 | 267 | 16 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD1 ARHGEF11 RASGRP3 RGPD3 DENND6B HERC2 DNMBP RIC1 RASAL2 DOCK8 ITSN1 MADD ARHGAP6 NPRL3 ARHGAP45 ARHGAP19 | 1.39e-03 | 507 | 267 | 16 | GO:0030695 |
| GeneOntologyMolecularFunction | enzyme activator activity | SRC RGPD1 ARHGEF11 WNK1 GTF3C4 RASGRP3 RGPD3 ALK RASAL2 ITSN1 MADD PPP4R3A DNTTIP1 PPP4R3B ARHGAP6 PPP2R5D NPRL3 ARHGAP45 ARHGAP19 | 1.39e-03 | 656 | 267 | 19 | GO:0008047 |
| GeneOntologyMolecularFunction | protein phosphatase activator activity | 1.40e-03 | 17 | 267 | 3 | GO:0072542 | |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 1.40e-03 | 17 | 267 | 3 | GO:0008574 | |
| GeneOntologyCellularComponent | cilium | OPN4 PEX6 EVC ADGRV1 PRAMEF1 PRAMEF2 PTGS1 NME8 SPTBN5 FSIP2 DNAAF5 CCDC66 SLC22A14 GLI2 STRC TAS2R20 SPATA4 STRCP1 NPHP1 HNF1A DYNC2H1 RTTN PRAMEF13 SPAG6 DNAH7 WDPCP SPAG5 EYS DNAH17 IQCB1 CROCC | 7.86e-07 | 898 | 272 | 31 | GO:0005929 |
| GeneOntologyCellularComponent | non-motile cilium | OPN4 PEX6 ADGRV1 PTGS1 SPTBN5 CCDC66 STRC STRCP1 NPHP1 HNF1A EYS IQCB1 | 1.06e-05 | 196 | 272 | 12 | GO:0097730 |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 1.44e-05 | 139 | 272 | 10 | GO:0097733 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 3.15e-05 | 47 | 272 | 6 | GO:0031462 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 3.31e-05 | 153 | 272 | 10 | GO:0097731 | |
| GeneOntologyCellularComponent | motile cilium | PRAMEF1 PRAMEF2 NME8 FSIP2 DNAAF5 SLC22A14 GLI2 TAS2R20 NPHP1 DYNC2H1 PRAMEF13 SPAG6 DNAH7 DNAH17 CROCC | 6.96e-05 | 355 | 272 | 15 | GO:0031514 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | CKAP5 DTNBP1 NME8 SPTBN5 GLI2 SPATA4 DYNC2H1 SPAG6 DNAH7 ARMCX3 WDPCP MADD AP3B2 DNAH17 | 7.60e-05 | 317 | 272 | 14 | GO:0032838 |
| GeneOntologyCellularComponent | cytoplasmic region | CKAP5 DTNBP1 NME8 SPTBN5 GLI2 SPATA4 DYNC2H1 SPAG6 DNAH7 ARMCX3 WDPCP MADD AP3B2 DNAH17 PHLDB2 | 8.14e-05 | 360 | 272 | 15 | GO:0099568 |
| GeneOntologyCellularComponent | photoreceptor outer segment | 1.03e-04 | 111 | 272 | 8 | GO:0001750 | |
| GeneOntologyCellularComponent | microtubule end | 1.27e-04 | 38 | 272 | 5 | GO:1990752 | |
| GeneOntologyCellularComponent | microtubule plus-end | 4.49e-04 | 28 | 272 | 4 | GO:0035371 | |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | TRPC4AP CAND1 CUL7 PRAMEF1 PRAMEF2 ZSWIM4 ANAPC7 PRAMEF13 PRAMEF14 PRAME | 4.81e-04 | 212 | 272 | 10 | GO:0031461 |
| GeneOntologyCellularComponent | spindle | DCDC1 RPS6KA1 CKAP5 WNK1 BIRC6 ABRAXAS2 KPNA7 ANAPC7 KIF11 KIF16B INO80 SPAG5 SMC3 IQCB1 MAPKBP1 KIF18B | 4.82e-04 | 471 | 272 | 16 | GO:0005819 |
| GeneOntologyCellularComponent | TTT Hsp90 cochaperone complex | 5.02e-04 | 3 | 272 | 2 | GO:0110078 | |
| GeneOntologyCellularComponent | annulate lamellae | 7.13e-04 | 14 | 272 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | myosin complex | 1.01e-03 | 59 | 272 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.26e-03 | 161 | 272 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | axoneme | 1.61e-03 | 207 | 272 | 9 | GO:0005930 | |
| GeneOntologyCellularComponent | ciliary plasm | 1.67e-03 | 208 | 272 | 9 | GO:0097014 | |
| GeneOntologyCellularComponent | nuclear body | ZBTB20 CDK12 ZC3H13 RNF112 RO60 NME8 TELO2 FASTK GLI2 CDT1 FANCL PATL1 INO80 VIRMA SPAG5 PPP4R3A PPP4R3B MTOR N4BP1 WDFY3 KIF18B TP53 SYMPK | 1.73e-03 | 903 | 272 | 23 | GO:0016604 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | TRPC4AP CAND1 UBQLN4 CUL7 DTNBP1 PRAMEF1 PRAMEF2 TRRAP MED24 RASGRP3 ZSWIM4 ANAPC7 RIC1 PATL1 MON1B PRAMEF13 POLR3F RPAP1 POLR3E MTOR PRAMEF14 TTI1 ELP2 PRAME | 2.07e-03 | 972 | 272 | 24 | GO:0140535 |
| GeneOntologyCellularComponent | Golgi apparatus subcompartment | BIRC6 COG6 CLVS2 DNMBP GOLGA3 RIC1 DOP1B MYO18A ATP2C1 ARSL AP3B2 LRBA VPS53 VPS13B | 2.11e-03 | 443 | 272 | 14 | GO:0098791 |
| GeneOntologyCellularComponent | trans-Golgi network | BIRC6 COG6 CLVS2 RIC1 DOP1B MYO18A ATP2C1 AP3B2 LRBA VPS53 VPS13B | 2.34e-03 | 306 | 272 | 11 | GO:0005802 |
| GeneOntologyCellularComponent | TORC1 complex | 2.44e-03 | 6 | 272 | 2 | GO:0031931 | |
| GeneOntologyCellularComponent | protein phosphatase 4 complex | 2.44e-03 | 6 | 272 | 2 | GO:0030289 | |
| GeneOntologyCellularComponent | sperm principal piece | 2.53e-03 | 44 | 272 | 4 | GO:0097228 | |
| GeneOntologyCellularComponent | midbody | 2.59e-03 | 222 | 272 | 9 | GO:0030496 | |
| Domain | ARM-type_fold | STK36 TRPC4AP CAND1 CKAP5 CUL7 USP9Y ARID1A TRRAP FOCAD DNAAF5 KPNA7 TELO2 MROH7 DOCK8 MROH2A UBR4 RTTN USP24 IPO4 MEI1 SPAG6 WDFY4 VIRMA ARMCX3 PPP4R3A PPP4R3B PPP2R5D MROH1 MTOR UNC45B AP3B2 IQCB1 TTI1 WDFY3 LRBA TNPO3 IPO11 SYMPK | 4.80e-23 | 339 | 268 | 38 | IPR016024 |
| Domain | ARM-like | STK36 CAND1 CKAP5 CUL7 USP9Y ARID1A TRRAP DNAAF5 KPNA7 TELO2 MROH7 DOCK8 MROH2A RTTN IPO4 MEI1 SPAG6 WDFY4 ARMCX3 PPP4R3A PPP4R3B MROH1 MTOR UNC45B AP3B2 IQCB1 TTI1 WDFY3 LRBA TNPO3 IPO11 SYMPK | 2.90e-20 | 270 | 268 | 32 | IPR011989 |
| Domain | - | STK36 CAND1 CKAP5 CUL7 ARID1A TRRAP DNAAF5 KPNA7 TELO2 MROH7 RTTN IPO4 SPAG6 WDFY4 ARMCX3 MROH1 MTOR UNC45B AP3B2 TTI1 WDFY3 LRBA TNPO3 IPO11 SYMPK | 1.59e-15 | 222 | 268 | 25 | 1.25.10.10 |
| Domain | HEAT | 8.91e-09 | 58 | 268 | 10 | IPR000357 | |
| Domain | HEAT | 3.72e-07 | 48 | 268 | 8 | PF02985 | |
| Domain | HEAT_REPEAT | 6.83e-07 | 70 | 268 | 9 | PS50077 | |
| Domain | BEACH | 4.94e-06 | 9 | 268 | 4 | PS50197 | |
| Domain | Beach | 4.94e-06 | 9 | 268 | 4 | PF02138 | |
| Domain | - | 4.94e-06 | 9 | 268 | 4 | 1.10.1540.10 | |
| Domain | Beach | 4.94e-06 | 9 | 268 | 4 | SM01026 | |
| Domain | BEACH_dom | 4.94e-06 | 9 | 268 | 4 | IPR000409 | |
| Domain | PH_dom-like | MYO10 RGPD1 ARHGEF11 SPTBN5 PTPN13 ANLN RGPD3 RASAL2 ITSN1 WDFY4 PPP4R3A PPP4R3B CMIP TNS4 WDFY3 LRBA CADPS2 PHLDB2 | 4.69e-05 | 426 | 268 | 18 | IPR011993 |
| Domain | HEAT_type_2 | 8.52e-05 | 17 | 268 | 4 | IPR021133 | |
| Domain | VWC_out | 1.36e-04 | 19 | 268 | 4 | SM00215 | |
| Domain | PRAME_family | 1.36e-04 | 19 | 268 | 4 | IPR026271 | |
| Domain | PH-BEACH_dom | 1.55e-04 | 8 | 268 | 3 | IPR023362 | |
| Domain | - | 1.55e-04 | 8 | 268 | 3 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.55e-04 | 8 | 268 | 3 | PS51783 | |
| Domain | SMK-1 | 2.05e-04 | 2 | 268 | 2 | PF04802 | |
| Domain | GREB1 | 2.05e-04 | 2 | 268 | 2 | PF15782 | |
| Domain | DUF625 | 2.05e-04 | 2 | 268 | 2 | IPR006887 | |
| Domain | GREB1 | 2.05e-04 | 2 | 268 | 2 | IPR028422 | |
| Domain | Cul7 | 6.10e-04 | 3 | 268 | 2 | PF11515 | |
| Domain | CPH_domain | 6.10e-04 | 3 | 268 | 2 | IPR021097 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | STK36 PPRC1 MYO10 CDK12 PEX6 ARID1A ARHGEF11 WNK1 TRRAP BIRC6 FOCAD PNPLA6 HERC2 DNMBP RIC1 PNPLA2 FRAS1 UBR4 RTTN INO80 WDR59 MADD CCDC142 RADIL KMT2D MROH1 CELSR3 RPAP1 MTOR NPRL3 WDFY3 LRBA MAPKBP1 MBD5 TNPO3 SYMPK | 1.05e-12 | 1105 | 278 | 36 | 35748872 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | DNAJB12 TBRG4 CAND1 NCKAP1 UBQLN4 SLC35E1 RO60 NUP205 SEMA4C MED24 DNAAF5 ESYT2 KIDINS220 PNPLA6 TELO2 KIF11 ABCC1 DYNC2H1 UBR4 USP24 IPO4 URGCP SPAG5 ATP2C1 PPP2R5D RPAP1 SMC3 MTOR ATP2A2 VPS53 TNPO3 IPO11 SYMPK | 1.44e-12 | 942 | 278 | 33 | 31073040 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TRPC4AP NCKAP1 SLC35E1 STYXL2 DTNBP1 WNK1 MELK GTF3C4 NME8 NUP205 DNAAF5 PTPN13 HELZ ANAPC7 RASAL2 NPHP1 HTRA2 DYNC2H1 MYO19 FANCL IPO4 URGCP SPAG5 PPP4R3A TXLNA PPP2R5D SMC3 MTOR IQCB1 TTI1 KIF18B VPS53 PRAME TNPO3 TP53 PHLDB2 IPO11 ARHGAP19 | 9.65e-12 | 1321 | 278 | 38 | 27173435 |
| Pubmed | STK36 CUL7 WNK1 BIRC6 SEMA4C ABRAXAS2 RASGRP3 TXNDC16 RIC1 UACA DYNC2H1 MON1B WDFY4 WDR59 THOC5 PPP4R3A RADIL CMIP ATP2C1 DNAH17 WSCD2 N4BP1 MBD5 | 1.63e-11 | 493 | 278 | 23 | 15368895 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CDK12 ZC3H13 CKAP5 TRRAP GTF3C4 MED24 ESYT2 PNPLA6 SLC41A3 ANLN HELZ CDT1 DNMBP DIP2B UACA ITSN1 USP24 MYO18A PATL1 REST VIRMA URGCP PPP4R3A KMT2D RPAP1 ATP2A2 PHLDB2 SYMPK | 3.82e-11 | 774 | 278 | 28 | 15302935 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NCKAP1 CKAP5 WNK1 MELK FSIP2 ESYT2 PTPN13 ANLN CCSER2 HELZ DNMBP RASAL2 KIF11 DOP1B FOXO1 DIP2B MAP3K6 VIRMA DNAH7 WDR59 MADD RADIL MTOR IQCB1 TNPO3 TP53 PHLDB2 OTOG ARHGAP19 | 9.06e-11 | 861 | 278 | 29 | 36931259 |
| Pubmed | ZNF536 NCKAP1 ZFYVE16 PPRC1 MYO10 CKAP5 FOCAD KIDINS220 SEMA6D DOP1B FRAS1 VIRMA MADD MROH1 RPAP1 PPIP5K1 MAPKBP1 CROCC VPS13B PDZD2 | 1.44e-10 | 407 | 278 | 20 | 12693553 | |
| Pubmed | DNAJB12 CAND1 SLC35E1 RO60 GTF3C4 DNAAF5 ESYT2 KIDINS220 PNPLA6 TELO2 MTARC2 HERC2 DYNC2H1 MYO19 IPO4 MAP3K6 ARMCX3 WDR59 PPP4R3B RPAP1 MTOR TTI1 VPS53 IPO11 | 1.67e-10 | 606 | 278 | 24 | 36538041 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | DNAJB12 TRPC4AP CAND1 ZBTB20 SRC EVC ADGRG1 SYNPO ADGRV1 ARID1A TRRAP DNAAF5 ESYT2 PTPN13 KIDINS220 PNPLA6 SLC41A3 GLI2 ABCC8 ZSWIM4 RIC1 DIP2B LMF1 UACA PATL1 DNTTIP1 ARHGAP6 PPP2R3A CMIP ATP2C1 MYH14 SAMD13 GREB1 LRBA CROCC MBD5 VPS13B PDZD2 | 3.01e-10 | 1489 | 278 | 38 | 28611215 |
| Pubmed | NR2C2 ZNF536 ZFYVE16 UBQLN4 RGPD1 CKAP5 BIRC6 GTF3C4 GREB1L PTPN13 RGPD3 CYB5R3 GOLGA3 KIF11 UBR4 USP24 SPAG5 KMT2D LRBA | 1.53e-09 | 418 | 278 | 19 | 34709266 | |
| Pubmed | DNAJB12 TBRG4 NCKAP1 CKAP5 GTF3C4 MED24 ESYT2 TELO2 COG6 ANAPC7 KIF11 IPO4 THOC5 PPP4R3A PPP2R5D SMC3 ELP2 TNPO3 TP53 IPO11 SYMPK | 6.30e-09 | 560 | 278 | 21 | 35241646 | |
| Pubmed | DNAJB12 CAND1 ILF2 NCKAP1 CKAP5 NUP205 DNAAF5 ESYT2 TELO2 KIF11 UBR4 USP24 IPO4 PPP4R3A SMC3 MTOR LRBA ATP2A2 TNPO3 TP53 IPO11 SYMPK | 1.23e-08 | 638 | 278 | 22 | 33239621 | |
| Pubmed | ZFYVE16 SLC35E1 WDR81 PEX6 SEMA4C ESYT2 PTPN13 KIDINS220 COG6 GOLGA3 RIC1 RASAL2 DOP1B KIF16B ARMCX3 WDR59 MADD LRBA VPS13B | 3.12e-08 | 504 | 278 | 19 | 34432599 | |
| Pubmed | DNAJB12 TBRG4 DNAAF5 TELO2 COG6 DOP1B IPO4 MTOR TTI1 ATP2A2 TNPO3 IPO11 | 3.25e-08 | 183 | 278 | 12 | 23956138 | |
| Pubmed | DCDC1 ZC3H13 TRRAP SPTBN5 HELZ KIF11 DYNC2H1 RTTN MYO18A CELSR3 MYH14 CROCC | 4.13e-08 | 187 | 278 | 12 | 26460568 | |
| Pubmed | CAND1 ILF2 NCKAP1 SRC RGPD1 CKAP5 WDR81 SYNPO ARHGEF11 RGPD3 HERC2 NOS1 GOLGA3 RASAL2 KIF11 DIP2B UACA ITSN1 UBR4 IPO4 VIRMA TXLNA PPP2R5D MTOR WDFY3 PHLDB2 | 7.92e-08 | 963 | 278 | 26 | 28671696 | |
| Pubmed | DNAJB12 CAND1 ILF2 CKAP5 BIRC6 MELK NUP205 ESYT2 KIDINS220 PNPLA6 RECQL4 CYB5R3 HELZ HERC2 GOLGA3 KIF11 DIP2B ABCC1 NIBAN1 DOCK8 UBR4 MYO18A IPO4 TXLNA ATP2C1 MYH14 MTOR LRBA ARHGAP45 | 8.12e-08 | 1168 | 278 | 29 | 19946888 | |
| Pubmed | ILF2 NCKAP1 ZC3H13 CKAP5 CUL7 ARID1A TRRAP BIRC6 NUP205 HELZ HERC2 UBR4 USP24 IPO4 VIRMA DDX27 MYH14 MTOR ATP2A2 TP53 SYMPK | 8.64e-08 | 653 | 278 | 21 | 22586326 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | TRPC4AP MYO10 SRC PRAMEF1 PRAMEF2 TRRAP MELK ABRAXAS2 SLC41A3 COG6 MROH7 ALDH3B1 RASAL2 DOP1B DIP2B USP24 PRAMEF13 HIBADH VIRMA DDX27 POLR3F CMIP SMC3 MYH14 MTOR PRAMEF14 DNAH17 KIF18B VPS53 SYMPK | 8.68e-08 | 1242 | 278 | 30 | 30973865 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | RNF112 CKAP5 MROH7 HERC2 UACA MYO18A IPO4 LRRC31 MYH14 MTOR ATP2A2 TP53 | 9.65e-08 | 202 | 278 | 12 | 33005030 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | TRPC4AP CAND1 ZFYVE16 RPS6KA1 CKAP5 NUP205 ABRAXAS2 DNAAF5 ESYT2 KIDINS220 TELO2 TXNDC16 HELZ KIF11 DIP2B UBR4 IPO4 DDX27 ARMCX3 PPP4R3A ATP2C1 RPAP1 WDR97 SMC3 MTOR TNPO3 | 9.87e-08 | 974 | 278 | 26 | 28675297 |
| Pubmed | STK36 CKAP5 CUL7 ARHGEF11 UACA MADD CELSR3 CADPS2 MBD5 PDZD2 | 1.04e-07 | 130 | 278 | 10 | 12421765 | |
| Pubmed | DNAJB12 ZNF536 ZFYVE16 CDK12 SLC35E1 WNK1 BIRC6 MELK GTF3C4 ANLN HELZ CDT1 ABCC1 LMF1 ITSN1 PATL1 WDR59 MADD PPP2R5D IQCB1 N4BP1 CROCC | 1.39e-07 | 733 | 278 | 22 | 34672954 | |
| Pubmed | NCKAP1 CUL7 ARID1A WNK1 BIRC6 GTF3C4 ABRAXAS2 PTPN13 CCSER2 HELZ RASAL2 DOCK8 RADIL PPP2R5D SMC3 PHLDB2 IPO11 | 1.44e-07 | 446 | 278 | 17 | 24255178 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.66e-07 | 104 | 278 | 9 | 31240132 | |
| Pubmed | ZFYVE16 CKAP5 ARID1A PTPN13 KIDINS220 CCSER2 HELZ DNMBP RASAL2 ITSN1 N4BP1 LRBA VPS13B | 2.38e-07 | 263 | 278 | 13 | 34702444 | |
| Pubmed | DNAJB12 CAND1 RO60 SYNPO CUL7 ARID1A GTF3C4 DNAAF5 PNPLA6 PMS1 ABCC1 MYO19 UBR4 MYO18A DDX27 THOC5 SPAG5 ATP2C1 TNPO3 TP53 | 2.40e-07 | 634 | 278 | 20 | 34591612 | |
| Pubmed | CDK12 RPS6KA1 SLC35E1 PEX6 RECQL4 HELZ RIC1 RASAL2 PMS1 DIP2B FRAS1 MYO19 PATL1 MAP3K6 URGCP MADD SPAG5 TXLNA RPAP1 ELP2 | 3.55e-07 | 650 | 278 | 20 | 38777146 | |
| Pubmed | CAND1 PPRC1 UBQLN4 CKAP5 NCKAP5 SYNPO USP9Y ARID1A GTF3C4 FOCAD PTPN13 DENND6B HERC2 GOLGA3 RASAL2 DOP1B VWF ITSN1 UBR4 DDX27 WDR59 MADD PPP4R3B CELSR3 MYH14 WDFY3 LRBA CADPS2 ATP2A2 | 5.82e-07 | 1285 | 278 | 29 | 35914814 | |
| Pubmed | CAND1 ILF2 RGPD1 CKAP5 TRRAP MED24 TELO2 ANLN GOLGA3 KIF11 ARMCX3 RPAP1 POLR3E TTI1 IPO11 | 7.05e-07 | 390 | 278 | 15 | 17643375 | |
| Pubmed | 7.42e-07 | 22 | 278 | 5 | 31729367 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | CAND1 ILF2 NCKAP1 RPS6KA1 RO60 WNK1 BIRC6 GTF3C4 NUP205 ABRAXAS2 DNAAF5 TELO2 DNMBP NIBAN1 UBR4 USP24 IPO4 ARMCX3 PPP4R3A PPP4R3B PPP2R5D MYH14 MTOR PRCP TTI1 ELP2 N4BP1 LRBA CROCC TNPO3 IPO11 | 7.88e-07 | 1455 | 278 | 31 | 22863883 |
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 8.08e-07 | 10 | 278 | 4 | 18160036 | |
| Pubmed | DNAJB12 NR2C2 ILF2 ZC3H13 ABRAXAS2 ESYT2 PTPN13 KIDINS220 PNPLA6 TELO2 CCSER2 HERC2 GOLGA3 RASAL2 PMS1 FRAS1 UACA DYNC2H1 ITSN1 UBR4 KIF16B MYO18A IPO4 DDX27 THOC5 TXLNA PPP2R5D RPAP1 ELP2 ATP2A2 VPS13B | 1.24e-06 | 1487 | 278 | 31 | 33957083 | |
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 1.26e-06 | 11 | 278 | 4 | 20427287 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | CUL7 TRRAP HELZ HERC2 ANAPC7 HTRA2 UBR4 USP24 URGCP SMC3 IQCB1 | 1.27e-06 | 212 | 278 | 11 | 33853758 |
| Pubmed | 1.47e-06 | 25 | 278 | 5 | 37451217 | ||
| Pubmed | 2.00e-06 | 104 | 278 | 8 | 9205841 | ||
| Pubmed | 2.01e-06 | 4 | 278 | 3 | 34645806 | ||
| Pubmed | SRC NCKAP5 SYNPO ARHGEF11 WNK1 HELZ HERC2 VWF ITSN1 MYO18A DDX27 MADD PPP4R3A MKNK1 SMC3 MBD5 | 2.28e-06 | 486 | 278 | 16 | 20936779 | |
| Pubmed | 2.66e-06 | 28 | 278 | 5 | 25089626 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | PTPN13 TELO2 CYB5R3 HERC2 GOLGA3 ABCC1 UACA COMMD5 MYO18A DDX27 ARMCX3 WDR59 ATP2C1 MYH14 MTOR TTI1 TNPO3 TP53 PHLDB2 IPO11 | 3.43e-06 | 754 | 278 | 20 | 33060197 |
| Pubmed | TBRG4 SYNPO GTF3C4 ESYT2 RASAL2 UBR4 IPO4 SPAG6 LENG9 URGCP THOC5 MADD TXLNA MBD5 TP53 IPO11 OTOG ARHGAP19 SYMPK | 3.48e-06 | 689 | 278 | 19 | 36543142 | |
| Pubmed | DNAJB12 CAND1 NCKAP1 CDK12 CKAP5 SLC35E1 ADGRG1 ARHGEF11 TRRAP SEMA4C GREB1L MED24 ESYT2 PTPN13 KIDINS220 PNPLA6 ANLN RGPD3 HELZ HERC2 DNMBP ANAPC7 UACA INO80 IPO4 VIRMA DDX27 DNTTIP1 CROCC ATP2A2 | 4.09e-06 | 1497 | 278 | 30 | 31527615 | |
| Pubmed | ZFYVE16 CUL7 DTNBP1 ARID1A BIRC6 ABRAXAS2 ESYT2 PTPN13 TELO2 HELZ HERC2 PMS1 ABCC1 DDX27 MADD PPP4R3A PPP4R3B PPP2R3A KMT2D PPP2R5D TTI1 ELP2 ATP2A2 SYMPK | 4.57e-06 | 1049 | 278 | 24 | 27880917 | |
| Pubmed | 4.99e-06 | 5 | 278 | 3 | 27448972 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | TBRG4 WDR81 TRRAP BIRC6 PTPN13 PNPLA6 TELO2 HERC2 ANAPC7 RASAL2 KIF11 ABCC1 LRRC57 UACA RTTN MYO18A MADD PRCP LRBA | 6.38e-06 | 719 | 278 | 19 | 35337019 |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | NR2C2 TBRG4 TRRAP MELK MED24 DNMBP FRAS1 DDX27 THOC5 KMT2D MYH14 KIF18B ATP2A2 VPS53 | 6.53e-06 | 410 | 278 | 14 | 26949251 |
| Pubmed | TBRG4 CAND1 CDK12 SYNPO ADGRV1 MELK NUP205 USP38 TELO2 CCSER2 DNMBP KIF16B INO80 URGCP PPP4R3B CELSR3 | 6.67e-06 | 529 | 278 | 16 | 14621295 | |
| Pubmed | DNAJB12 CAND1 CKAP5 BIRC6 DNAAF5 ESYT2 TELO2 HERC2 GOLGA3 UBR4 ARMCX3 RPAP1 MTOR TTI1 CADPS2 ATP2A2 TNPO3 IPO11 | 6.90e-06 | 657 | 278 | 18 | 36180527 | |
| Pubmed | 8.40e-06 | 35 | 278 | 5 | 19389355 | ||
| Pubmed | Multipotent CD15+ cancer stem cells in patched-1-deficient mouse medulloblastoma. | 9.93e-06 | 6 | 278 | 3 | 19487286 | |
| Pubmed | Oocyte-specific gene Oog1 suppresses the expression of spermatogenesis-specific genes in oocytes. | 1.12e-05 | 18 | 278 | 4 | 29731491 | |
| Pubmed | 1.12e-05 | 18 | 278 | 4 | 14675769 | ||
| Pubmed | 1.12e-05 | 18 | 278 | 4 | 23894331 | ||
| Pubmed | Oogenesin is a novel mouse protein expressed in oocytes and early cleavage-stage embryos. | 1.12e-05 | 18 | 278 | 4 | 12890732 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | CAND1 RPS6KA1 SRC ESYT2 PTPN13 KIDINS220 ANLN STRA6 RASAL2 DIP2B NIBAN1 LRRC57 UACA | 1.26e-05 | 377 | 278 | 13 | 38117590 |
| Pubmed | NR2C2 ZNF536 ILF2 RGPD1 CUL7 ARID1A TRRAP NUP205 MED24 GLI2 CYB5R3 HELZ HERC2 HNF1A UBR4 MYO18A PATL1 INO80 DDX27 DNTTIP1 LIPT1 KMT2D SMC3 MYH14 N4BP1 ATP2A2 TP53 SYMPK | 1.32e-05 | 1429 | 278 | 28 | 35140242 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | CAND1 ILF2 NCKAP1 CKAP5 ARID1A TRRAP BIRC6 MELK GTF3C4 NUP205 PNPLA6 ANLN RECQL4 HERC2 RASAL2 KIF11 MYO19 UBR4 IPO4 DDX27 WDR59 SMC3 MYH14 WDFY3 KIF18B ATP2A2 PHLDB2 | 1.37e-05 | 1353 | 278 | 27 | 29467282 |
| Pubmed | Pramel7 mediates ground-state pluripotency through proteasomal-epigenetic combined pathways. | 1.41e-05 | 19 | 278 | 4 | 28604677 | |
| Pubmed | A novel view of the transcriptome revealed from gene trapping in mouse embryonic stem cells. | 1.65e-05 | 40 | 278 | 5 | 17540781 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | ILF2 NCKAP1 CDK12 TRRAP BIRC6 GTF3C4 NUP205 ANLN RGPD3 KIF11 UBR4 IPO4 VIRMA RPAP1 SMC3 MTOR ELP2 LRBA | 1.74e-05 | 704 | 278 | 18 | 29955894 |
| Pubmed | 1.75e-05 | 20 | 278 | 4 | 26694250 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 1.75e-05 | 20 | 278 | 4 | 21425410 | |
| Pubmed | 1.75e-05 | 20 | 278 | 4 | 16580637 | ||
| Pubmed | ZNF536 TRPC4AP TBRG4 RGPD1 NRROS ARID1A RASAL2 TBX4 DYNC2H1 UBR4 USP24 KIF16B VIRMA DNAH7 KMT2D WDFY3 ARHGAP45 | 1.77e-05 | 638 | 278 | 17 | 31182584 | |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 1.81e-05 | 183 | 278 | 9 | 31932471 | |
| Pubmed | 1.99e-05 | 103 | 278 | 7 | 10819331 | ||
| Pubmed | HTRA2 TEX15 VIRMA KMT2D SNX25 PPIP5K1 LRBA TNPO3 VPS13B TP53 | 2.10e-05 | 234 | 278 | 10 | 36243803 | |
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 2.29e-05 | 71 | 278 | 6 | 28319113 | |
| Pubmed | CUL7 WNK1 NUP205 TELO2 ANAPC7 UBR4 MTOR IQCB1 VPS53 TNPO3 TP53 | 2.32e-05 | 288 | 278 | 11 | 23383273 | |
| Pubmed | 2.40e-05 | 106 | 278 | 7 | 18654987 | ||
| Pubmed | RUFY1 binds Arl8b and mediates endosome-to-TGN CI-M6PR retrieval for cargo sorting to lysosomes. | CAND1 ILF2 RO60 NUP205 FOCAD ESYT2 HELZ ANAPC7 KIF11 USP24 IPO4 ATP2A2 | 2.42e-05 | 344 | 278 | 12 | 36282215 |
| Pubmed | Expression of hedgehog signalling components in adult mouse testis. | 2.75e-05 | 8 | 278 | 3 | 16958114 | |
| Pubmed | Phosphorylation of SOCS1 Inhibits the SOCS1-p53 Tumor Suppressor Axis. | 2.75e-05 | 8 | 278 | 3 | 31101761 | |
| Pubmed | 2.75e-05 | 8 | 278 | 3 | 20810650 | ||
| Pubmed | 3.14e-05 | 23 | 278 | 4 | 19480014 | ||
| Pubmed | 3.30e-05 | 46 | 278 | 5 | 20301533 | ||
| Pubmed | SRC SEMA4C ESYT2 PTPN13 KIDINS220 SEMA6D GOLGA3 RASAL2 NPHP1 ABCC1 UACA LRBA PHLDB2 | 3.96e-05 | 421 | 278 | 13 | 36976175 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | ABCA1 WDR81 NCKAP5 PRAMEF1 PRAMEF2 WNK1 BIRC6 SLC41A3 RASGRP3 KIF16B PRAMEF13 PRAMEF14 | 4.09e-05 | 363 | 278 | 12 | 14691545 |
| Pubmed | 4.10e-05 | 9 | 278 | 3 | 24657168 | ||
| Pubmed | 4.10e-05 | 9 | 278 | 3 | 23263282 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | STK36 TBRG4 NCKAP1 RO60 TRRAP NUP205 ABRAXAS2 DNAAF5 TELO2 RASGRP3 HERC2 RASAL2 HNF1A UBR4 IPO4 DDX27 PPP4R3A PPP4R3B RADIL TXLNA SMC3 LRBA ATP2A2 TNPO3 IPO11 | 4.32e-05 | 1284 | 278 | 25 | 17353931 |
| Pubmed | Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. | 4.43e-05 | 25 | 278 | 4 | 12620990 | |
| Pubmed | Expression profiling in transgenic FVB/N embryonic stem cells overexpressing STAT3. | 5.20e-05 | 26 | 278 | 4 | 18500982 | |
| Pubmed | 5.57e-05 | 83 | 278 | 6 | 28794006 | ||
| Pubmed | 5.82e-05 | 10 | 278 | 3 | 26290144 | ||
| Pubmed | A point mutation in Myh10 causes major defects in heart development and body wall closure. | 5.82e-05 | 10 | 278 | 3 | 24825879 | |
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | CAND1 ILF2 RPS6KA1 TELO2 MYO18A IPO4 KMT2D MYH14 NPRL3 PRAME | 5.84e-05 | 264 | 278 | 10 | 32814769 |
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 5.96e-05 | 84 | 278 | 6 | 15203218 | |
| Pubmed | A protein network map of head and neck cancer reveals PIK3CA mutant drug sensitivity. | 5.96e-05 | 84 | 278 | 6 | 34591642 | |
| Pubmed | 6.37e-05 | 2 | 278 | 2 | 24391855 | ||
| Pubmed | 6.37e-05 | 2 | 278 | 2 | 32697937 | ||
| Pubmed | 6.37e-05 | 2 | 278 | 2 | 27773933 | ||
| Pubmed | 6.37e-05 | 2 | 278 | 2 | 16192272 | ||
| Pubmed | 6.37e-05 | 2 | 278 | 2 | 26494466 | ||
| Pubmed | Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo. | 6.37e-05 | 2 | 278 | 2 | 26577454 | |
| Pubmed | 6.37e-05 | 2 | 278 | 2 | 31707831 | ||
| Pubmed | Cdt1 transgenic mice develop lymphoblastic lymphoma in the absence of p53. | 6.37e-05 | 2 | 278 | 2 | 16261166 | |
| Pubmed | A puzzle over several decades: eye anomalies with FRAS1 and STRA6 mutations in the same family. | 6.37e-05 | 2 | 278 | 2 | 22283518 | |
| Interaction | GPR182 interactions | DNAJB12 TBRG4 CAND1 NCKAP1 SLC35E1 ADGRG1 NUP205 FOCAD DNAAF5 ESYT2 KIDINS220 TELO2 ALDH3B1 DOP1B MYO19 USP24 ATP2C1 MROH1 RPAP1 MTOR TTI1 WDFY3 VPS53 PRAME TNPO3 IPO11 SYMPK | 7.31e-11 | 455 | 265 | 27 | int:GPR182 |
| Interaction | PLEKHG7 interactions | WDR81 PEX6 CUL7 DNAAF5 RECQL4 HELZ DNMBP PNPLA2 HTRA2 WDR59 PPIP5K1 LRBA PRAME SYMPK | 1.20e-08 | 150 | 265 | 14 | int:PLEKHG7 |
| Interaction | NSUN5P1 interactions | 7.26e-08 | 59 | 265 | 9 | int:NSUN5P1 | |
| Interaction | CTDP1 interactions | TRRAP MED24 ESYT2 PTPN13 PNPLA6 TELO2 ANLN HELZ ABCC1 UACA VIRMA RPAP1 ELP2 PHLDB2 IPO11 | 1.08e-07 | 207 | 265 | 15 | int:CTDP1 |
| Interaction | IGHM interactions | TBRG4 UBQLN4 UBE2U ESYT2 DOP1B FOXO1 USP24 PATL1 MTOR PRAME VPS13B SYMPK | 1.52e-07 | 130 | 265 | 12 | int:IGHM |
| Interaction | NPTN interactions | TBRG4 FOCAD DNAAF5 TELO2 COG6 DOP1B DYNC2H1 USP24 IPO4 MROH1 MTOR TTI1 ATP2A2 PRAME TNPO3 IPO11 SYMPK | 1.78e-07 | 278 | 265 | 17 | int:NPTN |
| Interaction | LMBR1L interactions | DNAJB12 TBRG4 CAND1 NCKAP1 UBQLN4 SLC35E1 RO60 NUP205 SEMA4C MED24 DNAAF5 ESYT2 KIDINS220 PNPLA6 TELO2 KIF11 ABCC1 DYNC2H1 UBR4 USP24 IPO4 URGCP SPAG5 ATP2C1 PPP2R5D RPAP1 SMC3 MTOR ATP2A2 VPS53 TNPO3 IPO11 SYMPK | 3.28e-07 | 946 | 265 | 33 | int:LMBR1L |
| Interaction | COMTD1 interactions | TBRG4 CAND1 CKAP5 NUP205 DNAAF5 COG6 IPO4 PPP4R3A PPP4R3B MTOR TTI1 LRBA TNPO3 IPO11 | 4.39e-07 | 200 | 265 | 14 | int:COMTD1 |
| Interaction | D2HGDH interactions | CUL7 DNAAF5 TELO2 HELZ ANAPC7 PNPLA2 MAP3K6 WDR59 MADD NPRL3 LRBA VPS13B | 5.39e-07 | 146 | 265 | 12 | int:D2HGDH |
| Interaction | GYPA interactions | TBRG4 CKAP5 FOCAD DNAAF5 ANAPC7 DYNC2H1 USP24 MTOR IQCB1 TTI1 LRBA TNPO3 SYMPK | 5.43e-07 | 174 | 265 | 13 | int:GYPA |
| Interaction | CLEC16A interactions | DNAJB12 CAND1 SLC35E1 RO60 GTF3C4 DNAAF5 ESYT2 KIDINS220 PNPLA6 TELO2 MTARC2 HERC2 DYNC2H1 MYO19 IPO4 MAP3K6 VIRMA ARMCX3 WDR59 PPP4R3B RPAP1 MTOR TTI1 VPS53 IPO11 | 9.72e-07 | 629 | 265 | 25 | int:CLEC16A |
| Interaction | YWHAG interactions | NCKAP1 CDK12 RPS6KA1 ZC3H13 SRC CKAP5 SYNPO CUL7 WNK1 TRRAP MELK ESYT2 PTPN13 ANLN RECQL4 CCSER2 SYN2 HELZ DNMBP RASAL2 FOXO1 HNF1A UACA USP24 MAP3K6 VIRMA DNAH7 ANKRD55 DDX27 RADIL MTOR PPIP5K1 LRBA TNPO3 TP53 PHLDB2 OTOG ARHGAP19 | 1.16e-06 | 1248 | 265 | 38 | int:YWHAG |
| Interaction | GPR17 interactions | TBRG4 DNAAF5 COG6 ANAPC7 USP24 PPP4R3B RADIL PPP2R5D MTOR TTI1 WDFY3 LRBA ATP2A2 VPS53 TNPO3 IPO11 | 1.17e-06 | 283 | 265 | 16 | int:GPR17 |
| Interaction | SF3B3 interactions | NR2C2 CAND1 WDR81 PEX6 CUL7 TRRAP ANLN RECQL4 HELZ FOXO1 PNPLA2 WDFY4 VIRMA ANKRD55 WDR59 PPP4R3A RPAP1 SMC3 NPRL3 PPIP5K1 CADPS2 MBD5 TP53 | 1.46e-06 | 558 | 265 | 23 | int:SF3B3 |
| Interaction | INF2 interactions | RPS6KA1 WDR81 PEX6 SYNPO BIRC6 ANLN ALDH3B1 ANAPC7 ALK MYO19 MYO18A WDR59 RPAP1 NPRL3 PPIP5K1 B3GAT1 | 1.47e-06 | 288 | 265 | 16 | int:INF2 |
| Interaction | TOP3B interactions | STK36 PPRC1 MYO10 CDK12 PEX6 ARID1A ARHGEF11 WNK1 TRRAP BIRC6 FOCAD PNPLA6 FASTK HELZ HERC2 DNMBP RIC1 PNPLA2 FRAS1 UBR4 RTTN PATL1 INO80 IPO4 WDR59 MADD CCDC142 RADIL KMT2D MROH1 CELSR3 RPAP1 LRRC31 MTOR NPRL3 WDFY3 LRBA MAPKBP1 MBD5 TNPO3 TP53 SYMPK | 1.54e-06 | 1470 | 265 | 42 | int:TOP3B |
| Interaction | SULT1C4 interactions | 1.93e-06 | 110 | 265 | 10 | int:SULT1C4 | |
| Interaction | PFN1 interactions | NR2C2 CAND1 CUL7 ARHGEF11 WNK1 BIRC6 SEMA4C ESYT2 KIDINS220 ANLN RECQL4 DNMBP GOLGA3 KIF11 DOP1B DOCK8 ITSN1 PATL1 VIRMA SPAG5 PPP2R5D | 4.19e-06 | 509 | 265 | 21 | int:PFN1 |
| Interaction | PLEC interactions | NR2C2 CDK12 SYNPO CUL7 WNK1 ANLN CCDC62 RECQL4 HERC2 NPHP1 MYO19 MYO18A WDFY4 VIRMA URGCP SMC3 LRRC31 IQCB1 TP53 | 4.59e-06 | 430 | 265 | 19 | int:PLEC |
| Interaction | NUP160 interactions | NR2C2 RGPD1 CUL7 ARID1A TRRAP NUP205 ANLN RECQL4 WDFY4 VIRMA ANKRD55 TP53 | 5.80e-06 | 183 | 265 | 12 | int:NUP160 |
| Interaction | CLTC interactions | NR2C2 CAND1 SRC CKAP5 SYNPO CUL7 WNK1 KIDINS220 ANLN RECQL4 HELZ HERC2 NPHP1 MYO19 ITSN1 MYO18A WDFY4 VIRMA ANKRD55 ARMCX3 LRRC31 AP3B2 LRBA TP53 | 6.49e-06 | 655 | 265 | 24 | int:CLTC |
| Interaction | GAN interactions | DCDC1 ZC3H13 TRRAP SPTBN5 ANLN HELZ KIF11 DYNC2H1 RTTN MYO18A VIRMA CELSR3 MYH14 CROCC | 7.02e-06 | 253 | 265 | 14 | int:GAN |
| Interaction | MUL1 interactions | 7.47e-06 | 101 | 265 | 9 | int:MUL1 | |
| Interaction | EFNB1 interactions | SRC CKAP5 DNAAF5 PTPN13 RECQL4 IPO4 TMEM213 PPP4R3B RADIL IQCB1 TTI1 B3GAT1 TNPO3 IPO11 | 7.68e-06 | 255 | 265 | 14 | int:EFNB1 |
| Interaction | F12 interactions | 7.73e-06 | 77 | 265 | 8 | int:F12 | |
| Interaction | BAG2 interactions | DNAJB12 NR2C2 MYO10 CKAP5 CUL7 WNK1 ANLN RECQL4 RASAL2 KIF11 NPHP1 FOXO1 HTRA2 KIF16B VIRMA URGCP PPP2R5D RPAP1 IQCB1 GREB1 PRAME VPS13B TP53 | 8.80e-06 | 622 | 265 | 23 | int:BAG2 |
| Interaction | FAM174A interactions | TBRG4 PEX6 TELO2 ALDH3B1 MYO19 IPO4 MADD ATP2C1 MROH1 MTOR PRAME TNPO3 TP53 | 8.99e-06 | 224 | 265 | 13 | int:FAM174A |
| Interaction | YWHAZ interactions | NR2C2 NCKAP1 CKAP5 SYNPO CUL7 ARID1A WNK1 MELK FSIP2 PTPN13 ANLN RECQL4 CCSER2 SYN2 HERC2 DNMBP NOS1 GOLGA3 RASAL2 KIF11 FOXO1 HNF1A UACA MYO18A VIRMA ANKRD55 MADD SPAG5 RADIL TXLNA MTOR WDFY3 ATP2A2 TP53 PHLDB2 OTOG ARHGAP19 | 1.06e-05 | 1319 | 265 | 37 | int:YWHAZ |
| Interaction | CHIA interactions | 1.11e-05 | 39 | 265 | 6 | int:CHIA | |
| Interaction | GPR45 interactions | TBRG4 PEX6 NUP205 DNAAF5 TELO2 ANAPC7 MYO19 ATP2C1 MROH1 MTOR TTI1 WDFY3 TNPO3 GPR45 IPO11 | 1.12e-05 | 300 | 265 | 15 | int:GPR45 |
| Interaction | UNC93B1 interactions | DNAJB12 TBRG4 CAND1 SLC35E1 NUP205 DNAAF5 ESYT2 TELO2 COG6 CYB5R3 ABCC1 UBR4 SPAG5 MTOR ATP2A2 VPS53 TNPO3 IPO11 | 1.13e-05 | 417 | 265 | 18 | int:UNC93B1 |
| Interaction | MYL6B interactions | 1.29e-05 | 108 | 265 | 9 | int:MYL6B | |
| Interaction | FLNA interactions | NR2C2 TRPC4AP ILF2 ZBTB20 NCKAP1 SRC SYNPO CUL7 DNAAF5 ANLN TXNDC16 NPHP1 MYO19 MYO18A VIRMA ANKRD55 WDR59 TLR10 CMIP LRRC31 IQCB1 TP53 PHLDB2 | 1.69e-05 | 648 | 265 | 23 | int:FLNA |
| Interaction | RAB7A interactions | ZFYVE16 SLC35E1 WDR81 PEX6 CUL7 TRRAP SEMA4C ESYT2 PTPN13 KIDINS220 COG6 ANLN CYB5R3 GOLGA3 RIC1 RASAL2 DOP1B KIF16B MON1B VIRMA ARMCX3 WDR59 MADD B3GAT1 LRBA ATP2A2 VPS13B TP53 | 1.72e-05 | 886 | 265 | 28 | int:RAB7A |
| Interaction | LRRC31 interactions | RNF112 CKAP5 MROH7 HERC2 UACA MYO18A IPO4 LRRC31 MYH14 MTOR ATP2A2 TP53 | 1.83e-05 | 205 | 265 | 12 | int:LRRC31 |
| Interaction | NUP155 interactions | RGPD1 CUL7 NUP205 ESYT2 KIDINS220 ANLN RECQL4 HELZ ALDH3B1 ALK GOLGA3 KIF16B VIRMA KMT2D MYH14 ATP2A2 VPS13B TP53 IPO11 | 1.98e-05 | 477 | 265 | 19 | int:NUP155 |
| Interaction | C3orf18 interactions | 2.14e-05 | 115 | 265 | 9 | int:C3orf18 | |
| Interaction | SOHLH1 interactions | 2.14e-05 | 115 | 265 | 9 | int:SOHLH1 | |
| Interaction | MROH7 interactions | 2.20e-05 | 5 | 265 | 3 | int:MROH7 | |
| Interaction | MYO6 interactions | ZFYVE16 SYNPO SEMA4C ANLN RECQL4 CCSER2 ALK DOCK8 MYO19 ITSN1 MYO18A WDFY4 VIRMA LRRC31 B3GAT1 TP53 PHLDB2 | 2.27e-05 | 398 | 265 | 17 | int:MYO6 |
| Interaction | MYH10 interactions | NR2C2 BIRC6 ANLN HERC2 ALK GOLGA3 FOXO1 HTRA2 MYO19 WDFY4 VIRMA ANKRD55 PPP4R3A LRRC31 MYH14 IQCB1 | 2.37e-05 | 359 | 265 | 16 | int:MYH10 |
| Interaction | KRT8 interactions | DCDC1 BIRC6 NUP205 ESYT2 ANLN CCSER2 HELZ DNMBP GOLGA3 UACA UBR4 KIF16B PATL1 VIRMA SPAG5 IQCB1 VPS53 TP53 | 2.38e-05 | 441 | 265 | 18 | int:KRT8 |
| Interaction | STIP1 interactions | DNAJB12 NR2C2 CAND1 ILF2 NCKAP1 CKAP5 CUL7 NUP205 DNAAF5 ESYT2 TELO2 RECQL4 KIF11 FOXO1 DOCK8 UBR4 USP24 IPO4 WDFY4 VIRMA PPP4R3A SMC3 MTOR B3GAT1 LRBA ATP2A2 TNPO3 TP53 IPO11 SYMPK | 2.54e-05 | 1006 | 265 | 30 | int:STIP1 |
| Interaction | FPR1 interactions | 2.55e-05 | 147 | 265 | 10 | int:FPR1 | |
| Interaction | EEF1AKMT3 interactions | WDR81 CUL7 WNK1 DNAAF5 TELO2 HELZ ALDH3B1 DNMBP ANAPC7 MAP3K6 RPAP1 SMC3 NPRL3 PPIP5K1 VPS13B SYMPK | 2.80e-05 | 364 | 265 | 16 | int:EEF1AKMT3 |
| Interaction | B4GALT2 interactions | 2.82e-05 | 119 | 265 | 9 | int:B4GALT2 | |
| Interaction | BSG interactions | TBRG4 CAND1 CDK12 SLC35E1 TRRAP DNAAF5 TELO2 COG6 ANLN ABCC1 DOCK8 VIRMA ANKRD55 MTOR IQCB1 B3GAT1 WDFY3 ATP2A2 VPS53 TNPO3 IPO11 SYMPK | 3.39e-05 | 631 | 265 | 22 | int:BSG |
| Interaction | CD79B interactions | 3.43e-05 | 122 | 265 | 9 | int:CD79B | |
| Interaction | LDHA interactions | NR2C2 CAND1 RPS6KA1 CKAP5 CUL7 USP38 ANLN RECQL4 KIF11 NPHP1 HNF1A DOCK8 HIBADH VIRMA PRCP TP53 | 4.01e-05 | 375 | 265 | 16 | int:LDHA |
| Interaction | ACTB interactions | NR2C2 CAND1 ILF2 NCKAP1 MYO10 RO60 SYNPO ARID1A PXK FSIP2 CCDC66 PNPLA6 ANLN RECQL4 CYB5R3 SYN2 ALK NPHP1 DIP2B HNF1A ITSN1 MYO18A INO80 MAP3K6 WDFY4 VIRMA ANKRD55 SMC3 LRRC31 IQCB1 TP53 | 4.03e-05 | 1083 | 265 | 31 | int:ACTB |
| Interaction | FLII interactions | RO60 SYNPO TRRAP ANLN RECQL4 HERC2 ALK NPHP1 MYO19 MYO18A IPO4 VIRMA PPP4R3A LRRC31 | 4.35e-05 | 298 | 265 | 14 | int:FLII |
| Interaction | LAMP1 interactions | ILF2 NCKAP1 ZFYVE16 SRC TRRAP NUP205 ESYT2 PTPN13 KIDINS220 ANAPC7 GOLGA3 RASAL2 ABCC1 UBR4 MYO18A VIRMA WDR59 MYH14 MTOR NPRL3 LRBA TP53 | 4.60e-05 | 644 | 265 | 22 | int:LAMP1 |
| Interaction | TACSTD2 interactions | 5.32e-05 | 129 | 265 | 9 | int:TACSTD2 | |
| Interaction | RNF43 interactions | DNAJB12 ZFYVE16 CKAP5 ARID1A ABRAXAS2 PTPN13 KIDINS220 CCSER2 HELZ DNMBP RASAL2 ITSN1 DDX27 N4BP1 LRBA VPS13B TP53 | 5.47e-05 | 427 | 265 | 17 | int:RNF43 |
| Interaction | YWHAH interactions | NCKAP1 RPS6KA1 ZC3H13 SRC CKAP5 WNK1 MELK ESYT2 PTPN13 ANLN RECQL4 CCSER2 DNMBP RASAL2 KIF11 DOP1B FOXO1 DIP2B UACA MAP3K6 VIRMA DNAH7 ANKRD55 MADD RADIL MTOR IQCB1 LRBA PHLDB2 OTOG ARHGAP19 | 5.57e-05 | 1102 | 265 | 31 | int:YWHAH |
| Interaction | ACTR3 interactions | NR2C2 ZNF536 SYNPO CUL7 BIRC6 DNAAF5 ANLN RASGRP3 MYO19 MYO18A WDFY4 TNPO3 TP53 SYMPK | 5.59e-05 | 305 | 265 | 14 | int:ACTR3 |
| Interaction | UPP1 interactions | 7.49e-05 | 78 | 265 | 7 | int:UPP1 | |
| Interaction | SWSAP1 interactions | 7.71e-05 | 34 | 265 | 5 | int:SWSAP1 | |
| Interaction | C9orf78 interactions | DNAJB12 TBRG4 NCKAP1 CKAP5 GTF3C4 MED24 ESYT2 TELO2 COG6 ANAPC7 KIF11 IPO4 THOC5 PPP4R3A PPP2R5D SMC3 ELP2 TNPO3 TP53 IPO11 SYMPK | 7.74e-05 | 620 | 265 | 21 | int:C9orf78 |
| Interaction | CEP162 interactions | CKAP5 SYNPO ABRAXAS2 CCDC66 ANLN HERC2 MYO18A VIRMA TXLNA IQCB1 | 7.94e-05 | 168 | 265 | 10 | int:CEP162 |
| Interaction | MYLK interactions | 7.98e-05 | 106 | 265 | 8 | int:MYLK | |
| Interaction | RUVBL1 interactions | NR2C2 CAND1 RO60 CUL7 ARID1A TRRAP DNAAF5 TELO2 ANLN RECQL4 GOLGA3 DOCK8 ITSN1 INO80 VIRMA ANKRD55 DDX27 MYH14 MTOR TTI1 | 8.02e-05 | 575 | 265 | 20 | int:RUVBL1 |
| Interaction | HYOU1 interactions | DNAJB12 NR2C2 ADGRV1 CUL7 NUP205 ANLN RECQL4 TXNDC16 ALK NPHP1 WDFY4 VIRMA ARMCX3 TP53 | 8.45e-05 | 317 | 265 | 14 | int:HYOU1 |
| Interaction | MYO5A interactions | MYLK SYNPO DTNBP1 ARHGEF11 ANLN MYO19 MYO18A WDFY4 VIRMA LRRC31 MYH14 | 8.57e-05 | 204 | 265 | 11 | int:MYO5A |
| Interaction | ACTN4 interactions | ILF2 SRC RO60 SYNPO CUL7 ARID1A ANLN ALK FOXO1 MYO19 MYO18A INO80 WDFY4 VIRMA IQCB1 TP53 | 8.58e-05 | 400 | 265 | 16 | int:ACTN4 |
| Interaction | HCST interactions | TBRG4 FOCAD DNAAF5 PNPLA6 RTTN USP24 KLRK1 RADIL MTOR WDFY3 TNPO3 | 8.96e-05 | 205 | 265 | 11 | int:HCST |
| Interaction | HACD3 interactions | NR2C2 CAND1 CUL7 ESYT2 ANLN RECQL4 VIRMA PPP2R5D LRRC31 ATP2A2 TP53 ARHGAP19 | 9.19e-05 | 242 | 265 | 12 | int:HACD3 |
| Interaction | CIAO2A interactions | PEX6 DNAAF5 TELO2 HELZ DNMBP ANAPC7 PNPLA2 MROH1 PPIP5K1 TNS4 | 1.01e-04 | 173 | 265 | 10 | int:CIAO2A |
| Interaction | OPALIN interactions | TBRG4 NUP205 TELO2 DOP1B RTTN ATP2C1 MROH1 MTOR WDFY3 TNPO3 IPO11 | 1.06e-04 | 209 | 265 | 11 | int:OPALIN |
| Interaction | CYB5B interactions | TBRG4 CKAP5 FOCAD DNAAF5 COG6 CYB5R3 USP24 VIRMA MTOR LRBA TNPO3 IPO11 SYMPK | 1.10e-04 | 285 | 265 | 13 | int:CYB5B |
| Interaction | DOCK5 interactions | 1.10e-04 | 111 | 265 | 8 | int:DOCK5 | |
| Interaction | PHLDB2 interactions | 1.18e-04 | 143 | 265 | 9 | int:PHLDB2 | |
| Interaction | SMARCA5 interactions | NR2C2 ZC3H13 SRC CUL7 MED24 ANLN RECQL4 CDT1 GOLGA3 HNF1A INO80 REST VIRMA SMC3 TP53 SYMPK | 1.31e-04 | 415 | 265 | 16 | int:SMARCA5 |
| Interaction | P2RY8 interactions | NUP205 DNAAF5 TELO2 ATP2C1 MROH1 MTOR TTI1 PRAME TNPO3 IPO11 | 1.34e-04 | 179 | 265 | 10 | int:P2RY8 |
| Interaction | C19orf38 interactions | 1.39e-04 | 86 | 265 | 7 | int:C19orf38 | |
| Interaction | PGRMC1 interactions | MYLK STYXL2 CUL7 DNAAF5 ESYT2 RECQL4 UBR4 USP24 VIRMA TMEM213 PPP2R5D MTOR B3GAT1 ATP2A2 ARHGAP19 | 1.43e-04 | 375 | 265 | 15 | int:PGRMC1 |
| Interaction | HDAC1 interactions | NR2C2 ZNF536 ZFYVE16 UBQLN4 CKAP5 RO60 ARID1A BIRC6 PTPN13 USP38 ANLN GLI2 RECQL4 GOLGA3 UBR4 USP24 REST VIRMA THOC5 SPAG5 PPP4R3A DNTTIP1 KMT2D SMC3 MYH14 LRBA CROCC TNPO3 TP53 SYMPK | 1.45e-04 | 1108 | 265 | 30 | int:HDAC1 |
| Interaction | PPRC1 interactions | 1.47e-04 | 21 | 265 | 4 | int:PPRC1 | |
| Interaction | AFAP1 interactions | 1.48e-04 | 61 | 265 | 6 | int:AFAP1 | |
| Interaction | TMEM165 interactions | 1.50e-04 | 116 | 265 | 8 | int:TMEM165 | |
| Interaction | MYL6 interactions | NR2C2 MYLK TRRAP ANLN RECQL4 MYO19 MYO18A IPO4 WDFY4 VIRMA LRRC31 MYH14 | 1.50e-04 | 255 | 265 | 12 | int:MYL6 |
| Interaction | MROH1 interactions | 1.51e-04 | 39 | 265 | 5 | int:MROH1 | |
| Interaction | PPARD interactions | 1.59e-04 | 117 | 265 | 8 | int:PPARD | |
| Interaction | ARHGEF12 interactions | 1.59e-04 | 117 | 265 | 8 | int:ARHGEF12 | |
| Interaction | GOLGA1 interactions | RGPD1 BIRC6 PTPN13 CCSER2 DNMBP GOLGA3 UBR4 USP24 VIRMA RPAP1 | 1.61e-04 | 183 | 265 | 10 | int:GOLGA1 |
| Interaction | CEP128 interactions | NCKAP1 CKAP5 NUP205 CCDC66 CCSER2 RASAL2 NPHP1 VIRMA TXLNA IQCB1 TP53 PHLDB2 IPO11 | 1.65e-04 | 297 | 265 | 13 | int:CEP128 |
| Interaction | TUBB4B interactions | NR2C2 CAND1 CKAP5 CUL7 TRRAP MELK ANLN RECQL4 HERC2 ALK UBR4 REST VIRMA ANKRD55 MADD SPAG5 PRCP IQCB1 TP53 | 1.67e-04 | 560 | 265 | 19 | int:TUBB4B |
| Interaction | DNAJC7 interactions | DNAJB12 SYNPO CUL7 TRRAP TELO2 RECQL4 HERC2 NPHP1 DYNC2H1 IPO4 URGCP MKNK1 RPAP1 GREB1 VPS13B TP53 | 1.72e-04 | 425 | 265 | 16 | int:DNAJC7 |
| Interaction | OR2C1 interactions | 1.72e-04 | 2 | 265 | 2 | int:OR2C1 | |
| Interaction | STON2 interactions | 1.73e-04 | 89 | 265 | 7 | int:STON2 | |
| Interaction | CLTB interactions | 1.76e-04 | 185 | 265 | 10 | int:CLTB | |
| Interaction | YWHAB interactions | NCKAP1 RPS6KA1 SRC CUL7 WNK1 TRRAP MELK ESYT2 PTPN13 ANLN RECQL4 CCSER2 SYN2 DNMBP RASAL2 FOXO1 HNF1A UACA VIRMA ANKRD55 RADIL PPP2R5D MTOR IQCB1 TP53 PHLDB2 OTOG ARHGAP19 | 1.77e-04 | 1014 | 265 | 28 | int:YWHAB |
| Interaction | CCDC144BP interactions | 1.78e-04 | 9 | 265 | 3 | int:CCDC144BP | |
| Interaction | KPNA2 interactions | NR2C2 CAND1 CUL7 TRRAP ANLN RECQL4 CDT1 PMS1 FOXO1 MROH2A REST VIRMA ANKRD55 PPP4R3A POLR3F KIF18B MBD5 TP53 | 1.89e-04 | 519 | 265 | 18 | int:KPNA2 |
| Interaction | ARPC2 interactions | MYO10 SYNPO CUL7 TRRAP ANLN MYO19 WDFY4 PPP2R5D TNPO3 PHLDB2 | 1.92e-04 | 187 | 265 | 10 | int:ARPC2 |
| Interaction | MFSD4A interactions | TBRG4 CAND1 SLC35E1 DNAAF5 TELO2 DOP1B MTOR TTI1 PRAME TNPO3 IPO11 | 2.03e-04 | 225 | 265 | 11 | int:MFSD4A |
| Interaction | MOV10 interactions | NR2C2 TBRG4 CAND1 ILF2 CDK12 WDR81 SYNPO ARID1A NUP205 GREB1L DNAAF5 CCDC66 PNPLA6 FASTK ANLN RECQL4 CYB5R3 HELZ PMS1 UBR4 MYO18A PATL1 IPO4 VIRMA MKNK1 TXLNA MTOR ELP2 WDFY3 LRBA KIF18B PRAME TP53 | 2.12e-04 | 1297 | 265 | 33 | int:MOV10 |
| Interaction | SHMT2 interactions | NR2C2 TBRG4 CAND1 ILF2 MYLK WDR81 EVC CUL7 ARID1A NUP205 ABRAXAS2 ANLN DOCK8 UBR4 MYO18A MAP3K6 VIRMA MADD MTOR ELP2 WDFY3 | 2.30e-04 | 671 | 265 | 21 | int:SHMT2 |
| Interaction | PTGES3 interactions | NR2C2 MYLK ZC3H13 MELK FASTK RECQL4 ANAPC7 DIP2B ABCC1 PNPLA2 VIRMA URGCP PPP2R5D GREB1 KIF18B TP53 | 2.36e-04 | 437 | 265 | 16 | int:PTGES3 |
| Interaction | TTC3 interactions | 2.38e-04 | 124 | 265 | 8 | int:TTC3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 3.43e-06 | 147 | 277 | 8 | chr15q15 | |
| Cytoband | 12q24.11 | 4.62e-05 | 33 | 277 | 4 | 12q24.11 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.20e-06 | 9 | 182 | 4 | 1230 | |
| GeneFamily | PRAME family | 3.56e-06 | 24 | 182 | 5 | 686 | |
| GeneFamily | Armadillo repeat containing|Importins | 2.72e-05 | 18 | 182 | 4 | 596 | |
| GeneFamily | Maestro heat like repeat containing | 1.56e-04 | 11 | 182 | 3 | 636 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 1.58e-04 | 51 | 182 | 5 | 870 | |
| GeneFamily | ATP binding cassette subfamily C | 2.66e-04 | 13 | 182 | 3 | 807 | |
| GeneFamily | TTT complex | 3.00e-04 | 3 | 182 | 2 | 1320 | |
| GeneFamily | PDZ domain containing | 8.86e-04 | 152 | 182 | 7 | 1220 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 2.05e-03 | 7 | 182 | 2 | 917 | |
| GeneFamily | ATPases Ca2+ transporting | 3.46e-03 | 9 | 182 | 2 | 1209 | |
| GeneFamily | NME/NM23 family | 3.46e-03 | 9 | 182 | 2 | 961 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP | ZC3H13 ADGRV1 PXK MED24 KPNA7 CCDC66 FAM118A KIF11 ABCC1 PATL1 INO80 ARMCX3 ABHD16B PRCP | 3.05e-08 | 200 | 276 | 14 | M8264 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CAND1 ZBTB20 NCKAP1 ZFYVE16 MYO10 CKAP5 TRRAP MELK PTPN13 KIDINS220 CCSER2 HELZ DNMBP KIF11 DOP1B PMS1 ABCC1 ITSN1 USP24 PPP2R3A ATP2C1 SMC3 N4BP1 WDFY3 VPS13B MYBL1 ARHGAP19 | 4.49e-07 | 856 | 276 | 27 | M4500 |
| Coexpression | GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP | NUP205 BLK ANLN RASGRP3 KIF11 NIBAN1 TEX15 WDFY4 PPP2R3A CD19 | 1.53e-05 | 172 | 276 | 10 | M8932 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | MYO10 CKAP5 ARID1A WNK1 BIRC6 NUP205 RIC1 DOCK8 USP24 ATP2A2 | 2.26e-05 | 180 | 276 | 10 | M8239 |
| Coexpression | GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP | CKAP5 MED24 COG6 ANLN ANAPC7 KIF11 WDPCP SPAG5 KIF18B ARHGAP19 | 2.49e-05 | 182 | 276 | 10 | M8126 |
| Coexpression | GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_DN | ABCA1 ZFYVE16 RPS6KA1 CUL7 ARID1A MED24 KIF16B CLYBL SNX25 VPS13B | 2.86e-05 | 185 | 276 | 10 | M8824 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | TBRG4 ILF2 CKAP5 TRRAP NUP205 FOCAD DNAAF5 CDT1 KIF11 DOP1B PMS1 HTRA2 USP24 IPO4 DDX27 THOC5 SPAG5 POLR3E KIF18B | 3.00e-05 | 612 | 276 | 19 | M4772 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | CAND1 ZFYVE16 CKAP5 RO60 ADGRV1 ARID1A BIRC6 GTF3C4 USP38 ZFP69B DIP2B WDFY3 VPS13B | 2.82e-10 | 193 | 277 | 13 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | ZBTB20 NCKAP5 FOXO1 DIP2B FRAS1 ARHGAP6 CMIP LRBA MBD5 VPS13B PDZD2 | 3.61e-08 | 192 | 277 | 11 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | ZBTB20 ADGRV1 PTPN13 SNX25 WDFY3 LRBA CADPS2 MBD5 VPS13B PDZD2 | 4.88e-07 | 198 | 277 | 10 | 1996373bdccc55aac347d349bd22f6aad6d0c668 |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | ZBTB20 BIRC6 FOCAD DIP2B WDPCP WDFY3 LRBA CADPS2 MBD5 VPS13B | 5.11e-07 | 199 | 277 | 10 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.48e-07 | 160 | 277 | 9 | 7ad065337ac802de52c15ee715f6b78a3eed0cef | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-06 | 166 | 277 | 9 | f62db9d9b6c9dd8f2afcaea0fc5f8c69f50205b2 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-06 | 176 | 277 | 9 | 4bba41ebf9dd187c8705a6997ed039878de62b4e | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.99e-06 | 180 | 277 | 9 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | 343B-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.28e-06 | 183 | 277 | 9 | 807d64deaf4e50dccf6f831f88578a6d903c1421 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.72e-06 | 187 | 277 | 9 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.97e-06 | 189 | 277 | 9 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 3.10e-06 | 190 | 277 | 9 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.10e-06 | 190 | 277 | 9 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.68e-06 | 194 | 277 | 9 | d790cfff3664e46fe2fd2f6b0c26896799927845 | |
| ToppCell | BAL-Severe-cDC_11|Severe / Compartment, Disease Groups and Clusters | 3.84e-06 | 195 | 277 | 9 | 2d31a1c2878c86a49a278b6c7decafabf26c3a5c | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.17e-06 | 197 | 277 | 9 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.53e-06 | 199 | 277 | 9 | 6748d4f76703360071d5f2026d9d06bf30ccfb6d | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.53e-06 | 199 | 277 | 9 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | TCGA-Cervix-Primary_Tumor|TCGA-Cervix / Sample_Type by Project: Shred V9 | 4.53e-06 | 199 | 277 | 9 | ef6fde26af2ca9e6cde198ac0e14e03d9ab398f8 | |
| ToppCell | TCGA-Lung-Primary_Tumor|TCGA-Lung / Sample_Type by Project: Shred V9 | 4.53e-06 | 199 | 277 | 9 | d1d035e987280607266171094db5d6362efe1ad5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.53e-06 | 199 | 277 | 9 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-FOXM1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.71e-06 | 200 | 277 | 9 | 4cfe08878a6981bf7b3567f9e82192d8f060ddde | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 4.71e-06 | 200 | 277 | 9 | e16bde12326f0cfc4d03f9307cba0e21ea2389cb | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 6.16e-06 | 156 | 277 | 8 | 63b8cf14361b282872bc1c5b65d9fbc83e81a089 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.46e-06 | 157 | 277 | 8 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.77e-06 | 161 | 277 | 8 | 4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-06 | 163 | 277 | 8 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.50e-06 | 163 | 277 | 8 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.72e-06 | 166 | 277 | 8 | 575c325db88d6909cdf0d5e664bd9098b89d4401 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 169 | 277 | 8 | 0bc8ef341ce307b19018d4ac8de0a4d04254209d | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.14e-05 | 122 | 277 | 7 | 1ed865f0ecfe304fb86313ff51c04e9052357270 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 1.16e-05 | 170 | 277 | 8 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | PSB-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.26e-05 | 172 | 277 | 8 | 57b91bcce3f122f3d3267cf4d3a3ef67842caa9a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 173 | 277 | 8 | a25459b8140b0dbcb73e3b4cc1407b679229f25c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 174 | 277 | 8 | c26eac176e9b0cba385630fdc60e0314a4e4caac | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 174 | 277 | 8 | a0641908ab6feaca5cd07142d7429983a2f68668 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-05 | 175 | 277 | 8 | 0b1aaa028ba844d4bcb4509fdab8bee648373935 | |
| ToppCell | ICU-NoSEP-Myeloid-cDC1|ICU-NoSEP / Disease, Lineage and Cell Type | 1.55e-05 | 177 | 277 | 8 | 33cd2c183ee8b597012efcbcae72131ac6beaf4e | |
| ToppCell | control-Lymphoid-B_cell|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.82e-05 | 181 | 277 | 8 | e414303bb90e5fe7b667c2acf9a50f8694b90e54 | |
| ToppCell | facs-Skin-Skin_Anagen-18m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 182 | 277 | 8 | 0fc45214f0b0766f69be6eff69cc4bec574023aa | |
| ToppCell | NS-control-d_0-4-Lymphoid-B_cell|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.89e-05 | 182 | 277 | 8 | 4b9b55154a79992112c1c467e8752c3cdbb541d9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-05 | 183 | 277 | 8 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | 10x5'-blood-Myeloid_Dendritic-DC1|blood / Manually curated celltypes from each tissue | 2.05e-05 | 184 | 277 | 8 | 09fa465d1852b9b7e0405c27d4e5de276c9ba871 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-DC1|bone_marrow / Manually curated celltypes from each tissue | 2.05e-05 | 184 | 277 | 8 | ee295f6fa898da53883e1358b17f2c2dd177e9a7 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Lymphocytic-B_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-05 | 186 | 277 | 8 | 124a618a0911aba9fc2a071dc3ca40fc003bb1ed | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.21e-05 | 186 | 277 | 8 | 77592a6397b44b2b59a4fc39d7224dd95343efe6 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.21e-05 | 186 | 277 | 8 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-05 | 186 | 277 | 8 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.21e-05 | 186 | 277 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.30e-05 | 187 | 277 | 8 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 189 | 277 | 8 | 6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 189 | 277 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 189 | 277 | 8 | 875df61ee48baa5142ba4d2427bdec1c53e5a828 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-05 | 189 | 277 | 8 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 189 | 277 | 8 | 3ae479ec7e00c57127cbe51a398329b10ca9848c | |
| ToppCell | facs-Brain_Myeloid-Striatum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 189 | 277 | 8 | 97ef5215d841ff366a3e3682cd9bd04100cbfde0 | |
| ToppCell | CF-Lymphoid-B_cell|CF / Disease state, Lineage and Cell class | 2.58e-05 | 190 | 277 | 8 | 374d8fd63c733178acab07682ed1519693efab45 | |
| ToppCell | COVID-19_Severe-Lymphoid_B-B_memory|COVID-19_Severe / Disease group, lineage and cell class | 2.58e-05 | 190 | 277 | 8 | b6510c419a15ed049c0a0a6a6697b643668741c3 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-05 | 139 | 277 | 7 | d96e5c17582f1576fa09d6bad35c418b6248448c | |
| ToppCell | droplet-Skin-nan-21m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-05 | 192 | 277 | 8 | 96f23d6e8604d1cb24910d3118d8171b57c93e14 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.78e-05 | 192 | 277 | 8 | 72f936f03bb9b58c1ccaaf8270c07f5bbf2ac355 | |
| ToppCell | AT1_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.78e-05 | 192 | 277 | 8 | 0444f9e9cef7403e220e862b5a787443d3f5c9ac | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.78e-05 | 192 | 277 | 8 | dac61f0b374f6f9476eedce97f341f26c1bc037c | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.88e-05 | 193 | 277 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | MS-mDC1|MS / Condition, Cell_class and T cell subcluster | 2.88e-05 | 193 | 277 | 8 | 4d08ebf555954d6a873a4b4c4d661dc5dd8a5bcb | |
| ToppCell | MS-mDC1-|MS / Condition, Cell_class and T cell subcluster | 2.88e-05 | 193 | 277 | 8 | ce873f20b93e3b57c9385ee10d4becebe32ada06 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.99e-05 | 194 | 277 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | IPF-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 2.99e-05 | 194 | 277 | 8 | e8a9005963704286bcc50785bda8d7d63ec001b1 | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.10e-05 | 195 | 277 | 8 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | Healthy/Control-T/NK_proliferative|Healthy/Control / Disease group and Cell class | 3.10e-05 | 195 | 277 | 8 | 957458fdc39723f4a31bd7fd3ce32891aa3fd462 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-05 | 195 | 277 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 3.10e-05 | 195 | 277 | 8 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.10e-05 | 195 | 277 | 8 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.22e-05 | 196 | 277 | 8 | 0644bd14a944b9c9759a295dfdd5e67a4775f20a | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-05 | 196 | 277 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.22e-05 | 196 | 277 | 8 | 20383d576708b7e4bfce3e9fe40548cce496e3cb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.33e-05 | 144 | 277 | 7 | 3d880c140db4a0e7602bfddcb73a42a68c2848d5 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-05 | 198 | 277 | 8 | f801157468e59b5d049f703feadc9bb0f11e85cc | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.58e-05 | 199 | 277 | 8 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-B_memory|COVID-19_Severe / Disease, condition lineage and cell class | 3.58e-05 | 199 | 277 | 8 | 24c05faa825c9d55279956469862440f9914a280 | |
| ToppCell | mild-B_memory|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.58e-05 | 199 | 277 | 8 | e6ac9a0959b0de2c6a99298feb7715aa80ade1dd | |
| ToppCell | mild-B_memory|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.58e-05 | 199 | 277 | 8 | 025bb65629d9e20c374e8f1ba08c36d1bb569190 | |
| ToppCell | Control_saline-Endothelial-Endothelial-FOXM1|Control_saline / Treatment groups by lineage, cell group, cell type | 3.71e-05 | 200 | 277 | 8 | 9bbc7b5561151f6ff65f40b3226271def732e5d9 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 3.71e-05 | 200 | 277 | 8 | e3ad8d592686a5d1e1fb8dd05c2f00eac4c5738f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 3.71e-05 | 200 | 277 | 8 | d46a19274c2836ce7494790ce513764dedcadc79 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.71e-05 | 200 | 277 | 8 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.71e-05 | 200 | 277 | 8 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.71e-05 | 200 | 277 | 8 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 3.71e-05 | 200 | 277 | 8 | 1cbb62df4ea1631fef8497e1702175605d0869e7 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-OPC_related-Oligodendrocyte/OPC|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 3.71e-05 | 200 | 277 | 8 | 4db894cfb80fd1f9e01133f345eefd78edd4bc43 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.71e-05 | 200 | 277 | 8 | 5b014c658eecc5e73679e5feb7a2aaa3d297001d | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_memory-B_memory-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.14e-05 | 149 | 277 | 7 | 2cd860b96ed4be4d26844085d464961c1418054a | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic_-_developing-DN4_thymocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.14e-05 | 149 | 277 | 7 | 89faa84af68d4727180f39718964bb3bc65d8fe6 | |
| ToppCell | PBMC-Severe-cDC_3|Severe / Compartment, Disease Groups and Clusters | 4.70e-05 | 152 | 277 | 7 | 1a3f8ed476aa9a39742b4684be2c704669e4a3d0 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.90e-05 | 153 | 277 | 7 | e7a074ea8232bacf924be78a244a8507c7e1ebc8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd|lymph-node_spleen / Manually curated celltypes from each tissue | 5.32e-05 | 155 | 277 | 7 | b0e456c4915076e1d38282e116a6eb3230ae80dc | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.54e-05 | 156 | 277 | 7 | ff39712c7a2dc1b85c598d5105789aa291dea726 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC1|368C / Donor, Lineage, Cell class and subclass (all cells) | 6.01e-05 | 158 | 277 | 7 | c276a259e20ee704e2d04baf693e8d677f96f654 | |
| ToppCell | normal-na-Lymphocytic_B-B_cell-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.03e-05 | 162 | 277 | 7 | ae292318d339305932457bb0e91430594f7a3dfa | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 7.03e-05 | 162 | 277 | 7 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| Computational | Response to DNA damage. | ILF2 MYLK PEX6 MELK MED24 RECQL4 HELZ KIF11 PMS1 ABCC1 MYO18A | 2.97e-05 | 187 | 139 | 11 | MODULE_244 |
| Disease | Malignant neoplasm of breast | SRC ARID1A WNK1 PTGS1 NME8 MROH7 HERC2 ALK RASAL2 SLC17A6 ABCC1 VWF DYNC2H1 UBR4 KIF16B MAP3K6 SPAG6 THOC5 SLC39A12 KMT2D MTOR UNC45B LRBA VPS13B GPR45 TP53 | 3.58e-06 | 1074 | 260 | 26 | C0006142 |
| Disease | red blood cell density measurement | STK36 DCDC1 CDK12 ADGRV1 ARHGEF11 WNK1 PXK NUP205 FOCAD CYB5R3 CDT1 KIF11 FOXO1 HNF1A ITSN1 INO80 ANKRD55 PPP4R3A ABHD16B CROCC VPS13B | 3.96e-05 | 880 | 260 | 21 | EFO_0007978 |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 5.31e-05 | 148 | 260 | 8 | C0279702 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | PEX6 ARID1A RECQL4 SYN2 DNMBP DIP2B COMMD5 SLC39A12 MROH1 ARHGAP45 | 5.63e-05 | 239 | 260 | 10 | EFO_0010934 |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 7.73e-05 | 2 | 260 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | Nephronophthisis 1 | 7.73e-05 | 2 | 260 | 2 | C4551979 | |
| Disease | rheumatoid arthritis, systemic lupus erythematosus | 7.75e-05 | 10 | 260 | 3 | EFO_0000685, MONDO_0007915 | |
| Disease | Sezary Syndrome | 8.81e-05 | 27 | 260 | 4 | C0036920 | |
| Disease | Renal Cell Carcinoma | 1.45e-04 | 128 | 260 | 7 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 1.45e-04 | 128 | 260 | 7 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 1.45e-04 | 128 | 260 | 7 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 1.45e-04 | 128 | 260 | 7 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 1.45e-04 | 128 | 260 | 7 | C1306837 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 1.54e-04 | 31 | 260 | 4 | C1335167 | |
| Disease | bilirubin measurement | ZBTB20 PEX6 ARID1A BIRC6 GLI2 CYB5R3 SYN2 CDT1 DNMBP HNF1A MROH2A SLCO1B7 PPP2R3A | 1.67e-04 | 442 | 260 | 13 | EFO_0004570 |
| Disease | Neurodevelopmental Disorders | 1.77e-04 | 93 | 260 | 6 | C1535926 | |
| Disease | non-high density lipoprotein cholesterol measurement | ABCA1 WDR81 PEX6 ARID1A PXK ESYT2 ADRB1 HELZ AMBN DIP2B HNF1A MYO1H MAP3K6 WDPCP CMIP ARSL TP53 | 2.19e-04 | 713 | 260 | 17 | EFO_0005689 |
| Disease | Maturity onset diabetes mellitus in young | 2.29e-04 | 14 | 260 | 3 | C0342276 | |
| Disease | ceramide measurement | ABCA1 CDK12 CYB5R3 HNF1A KIF16B SLCO1B7 EYS PPP1R36 ARHGAP45 | 2.56e-04 | 235 | 260 | 9 | EFO_0010222 |
| Disease | age at menarche | DNAJB12 ZBTB20 MYO10 ARID1A SEMA6D COG6 MYO1H INO80 MADD CMIP CLYBL WSCD2 GREB1 CADPS2 GPR45 | 2.81e-04 | 594 | 260 | 15 | EFO_0004703 |
| Disease | platelet crit | TBRG4 ZBTB20 NUP210L ADGRV1 ARID1A ARHGEF11 PXK NUP205 ADRB1 USP38 CYB5R3 SYN2 RASAL2 FOXO1 DIP2B VWF RTTN KIF16B REST TNPO3 | 3.27e-04 | 952 | 260 | 20 | EFO_0007985 |
| Disease | peripheral arterial disease, traffic air pollution measurement | 3.43e-04 | 194 | 260 | 8 | EFO_0004265, EFO_0007908 | |
| Disease | T-Cell Lymphoma | 3.48e-04 | 16 | 260 | 3 | C0079772 | |
| Disease | Monogenic diabetes | 3.48e-04 | 16 | 260 | 3 | C3888631 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.86e-04 | 303 | 260 | 10 | EFO_0004612, EFO_0020945 | |
| Disease | Fetal Alcohol Syndrome | 4.20e-04 | 17 | 260 | 3 | C0015923 | |
| Disease | Ciliopathies | 4.40e-04 | 110 | 260 | 6 | C4277690 | |
| Disease | Macrostomia | 4.59e-04 | 4 | 260 | 2 | C0024433 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 4.59e-04 | 4 | 260 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | Congenital small ears | 4.62e-04 | 41 | 260 | 4 | C0152423 | |
| Disease | phospholipids in large HDL measurement | 4.71e-04 | 73 | 260 | 5 | EFO_0022190 | |
| Disease | total cholesterol measurement, high density lipoprotein cholesterol measurement | ABCA1 ARID1A ADRB1 SYN2 HNF1A MYO1H KIF16B MADD CMIP MAPKBP1 | 5.22e-04 | 315 | 260 | 10 | EFO_0004574, EFO_0004612 |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 6.04e-04 | 321 | 260 | 10 | EFO_0004612, EFO_0004639 | |
| Disease | Heart Diseases | 7.19e-04 | 46 | 260 | 4 | C0018799 | |
| Disease | Partial Fetal Alcohol Syndrome | 7.60e-04 | 5 | 260 | 2 | C3661483 | |
| Disease | Aneuploidy | 7.60e-04 | 5 | 260 | 2 | C0002938 | |
| Disease | post-operative atrial fibrillation, response to surgery | 7.60e-04 | 5 | 260 | 2 | EFO_0009951, EFO_0009952 | |
| Disease | Basal Cell Nevus Syndrome | 7.60e-04 | 5 | 260 | 2 | C0004779 | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 7.60e-04 | 5 | 260 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | Alcohol Related Neurodevelopmental Disorder | 7.60e-04 | 5 | 260 | 2 | C0814154 | |
| Disease | high density lipoprotein particle size measurement | 8.09e-04 | 170 | 260 | 7 | EFO_0008592 | |
| Disease | sexual dimorphism measurement | ABCA1 TRPC4AP RGPD1 CNBD2 ARID1A SPTBN5 MED24 CCDC66 GLI2 DIP2B HNF1A TBX4 REST DDX27 MADD CMIP CD19 NPRL3 MAPKBP1 CROCC TP53 | 8.61e-04 | 1106 | 260 | 21 | EFO_0021796 |
| Disease | Schizophrenia | ABCA1 DTNBP1 ARHGEF11 TRRAP PTGS1 KCNH6 CLVS2 SYN2 ALDH3B1 NOS1 ALK SLC17A6 REST MTOR B3GAT1 CADPS2 ATP2A2 TP53 | 9.12e-04 | 883 | 260 | 18 | C0036341 |
| Disease | Ovarian Serous Adenocarcinoma | 1.05e-03 | 23 | 260 | 3 | C1335177 | |
| Disease | nephronophthisis (is_implicated_in) | 1.13e-03 | 6 | 260 | 2 | DOID:12712 (is_implicated_in) | |
| Disease | age at diagnosis, substance-related disorder | 1.13e-03 | 6 | 260 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | Alcohol Related Birth Defect | 1.13e-03 | 6 | 260 | 2 | C3146244 | |
| Disease | primary ciliary dyskinesia (is_implicated_in) | 1.13e-03 | 6 | 260 | 2 | DOID:9562 (is_implicated_in) | |
| Disease | phospholipids in medium HDL measurement | 1.41e-03 | 55 | 260 | 4 | EFO_0022295 | |
| Disease | free cholesterol to total lipids in very large HDL percentage | 1.41e-03 | 55 | 260 | 4 | EFO_0022288 | |
| Disease | endometrial adenocarcinoma (is_implicated_in) | 1.58e-03 | 7 | 260 | 2 | DOID:2870 (is_implicated_in) | |
| Disease | Glycosuria | 1.58e-03 | 7 | 260 | 2 | HP_0003076 | |
| Disease | Nephronophthisis, familial juvenile | 1.58e-03 | 7 | 260 | 2 | C1855681 | |
| Disease | Senior-Loken syndrome (is_implicated_in) | 1.58e-03 | 7 | 260 | 2 | DOID:0050576 (is_implicated_in) | |
| Disease | Renal dysplasia and retinal aplasia | 1.58e-03 | 7 | 260 | 2 | cv:C0403553 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 1.69e-03 | 27 | 260 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | total lipids in medium HDL measurement | 1.72e-03 | 58 | 260 | 4 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 1.72e-03 | 58 | 260 | 4 | EFO_0022267 | |
| Disease | cholesterol in medium HDL measurement | 1.83e-03 | 59 | 260 | 4 | EFO_0021903 | |
| Disease | gastric adenocarcinoma (is_marker_for) | 1.88e-03 | 28 | 260 | 3 | DOID:3717 (is_marker_for) | |
| Disease | lumbar disc degeneration | 1.88e-03 | 28 | 260 | 3 | EFO_0004994 | |
| Disease | Pigmented Basal Cell Carcinoma | 1.88e-03 | 28 | 260 | 3 | C1368275 | |
| Disease | cholesteryl ester measurement, high density lipoprotein cholesterol measurement | 1.90e-03 | 312 | 260 | 9 | EFO_0004612, EFO_0010351 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 1.95e-03 | 60 | 260 | 4 | EFO_0022282 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 2.03e-03 | 315 | 260 | 9 | EFO_0004612, EFO_0008591 | |
| Disease | free cholesterol in HDL measurement | 2.07e-03 | 61 | 260 | 4 | EFO_0022264 | |
| Disease | phospholipids in HDL measurement | 2.07e-03 | 61 | 260 | 4 | EFO_0022293 | |
| Disease | mean reticulocyte volume | PPRC1 NUP210L RPS6KA1 TRRAP NUP205 SYN2 FOXO1 ABCC1 ITSN1 RTTN REST PPP4R3A MTOR NPRL3 TP53 IPO11 | 2.08e-03 | 799 | 260 | 16 | EFO_0010701 |
| Disease | Bilateral Wilms Tumor | 2.09e-03 | 29 | 260 | 3 | C2930471 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 2.09e-03 | 29 | 260 | 3 | C0496920 | |
| Disease | Carcinoma, Basal Cell | 2.09e-03 | 29 | 260 | 3 | C4721806 | |
| Disease | Unilateral agenesis of kidney | 2.09e-03 | 8 | 260 | 2 | C0266294 | |
| Disease | Chromosomal Instability | 2.09e-03 | 8 | 260 | 2 | C1257806 | |
| Disease | low tension glaucoma (is_implicated_in) | 2.09e-03 | 8 | 260 | 2 | DOID:13544 (is_implicated_in) | |
| Disease | Ovarian Carcinoma | 2.30e-03 | 30 | 260 | 3 | C0029925 | |
| Disease | rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement | 2.33e-03 | 63 | 260 | 4 | EFO_0000685, EFO_0007791, EFO_0009459 | |
| Disease | total lipids in HDL measurement | 2.33e-03 | 63 | 260 | 4 | EFO_0022307 | |
| Disease | lipoprotein measurement | 2.41e-03 | 105 | 260 | 5 | EFO_0004732 | |
| Disease | central nervous system cancer | 2.53e-03 | 31 | 260 | 3 | EFO_0000326 | |
| Disease | Antihypertensive use measurement | 2.54e-03 | 265 | 260 | 8 | EFO_0009927 | |
| Disease | Glioma | 2.67e-03 | 9 | 260 | 2 | cv:C0017638 | |
| Disease | Carcinoma, Small Cell | 2.67e-03 | 9 | 260 | 2 | C0262584 | |
| Disease | anemia (phenotype), response to ribavirin | 2.67e-03 | 9 | 260 | 2 | EFO_0004272, GO_1901559 | |
| Disease | renovascular hypertension (implicated_via_orthology) | 2.67e-03 | 9 | 260 | 2 | DOID:1591 (implicated_via_orthology) | |
| Disease | glucose metabolism decline measurement, cingulate cortex measurement | 2.67e-03 | 9 | 260 | 2 | EFO_0007738, EFO_0009392 | |
| Disease | cancer (implicated_via_orthology) | 2.72e-03 | 268 | 260 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 2.77e-03 | 330 | 260 | 9 | EFO_0004529, EFO_0004612 | |
| Disease | rheumatoid arthritis | CDK12 SRC BLK TELO2 COG6 TXNDC16 WDFY4 ANKRD55 ABHD16B CLYBL TNPO3 | 2.83e-03 | 462 | 260 | 11 | EFO_0000685 |
| Disease | Disorder of eye | 2.85e-03 | 212 | 260 | 7 | C0015397 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.26e-03 | 276 | 260 | 8 | EFO_0004612, EFO_0020943 | |
| Disease | Asthma, Occupational | 3.32e-03 | 10 | 260 | 2 | C0264423 | |
| Disease | triple-negative breast cancer | 3.32e-03 | 10 | 260 | 2 | EFO_0005537 | |
| Disease | anti-topoisomerase-I-antibody-positive systemic scleroderma | 3.32e-03 | 10 | 260 | 2 | EFO_0008537 | |
| Disease | long QT syndrome (implicated_via_orthology) | 3.32e-03 | 10 | 260 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | creatinine measurement | CAND1 DCDC1 CDK12 RNF112 EVC ADGRV1 ARID1A BIRC6 BLK SYN2 HNF1A TBX4 INO80 ARMCX3 SLC1A7 CELSR3 AP3B2 MBD5 | 3.33e-03 | 995 | 260 | 18 | EFO_0004518 |
| Disease | hair colour measurement | DNAJB12 ZFYVE16 SRC ADGRV1 ARID1A SEMA6D CDT1 HERC2 FRAS1 MROH2A WDPCP KMT2D SNX25 | 3.39e-03 | 615 | 260 | 13 | EFO_0007822 |
| Disease | Polydactyly | 3.84e-03 | 117 | 260 | 5 | C0152427 | |
| Disease | Nephroblastoma | 3.90e-03 | 36 | 260 | 3 | C0027708 | |
| Disease | colon cancer (is_implicated_in) | 3.90e-03 | 36 | 260 | 3 | DOID:219 (is_implicated_in) | |
| Disease | risky sexual behaviour measurement | 3.96e-03 | 169 | 260 | 6 | EFO_0007877 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELTRMANTLLHVPNL | 101 | Q9P2W7 | |
| ILETMELLSQSRPRV | 231 | Q68DN1 | |
| TPRLQTLTNLFIMSL | 86 | P08588 | |
| LTLMPNASNLDKVLT | 506 | A0FGR8 | |
| STPADMQNILAVLLS | 1201 | Q9NYV4 | |
| LQQAVLSRQMPSESL | 261 | Q15018 | |
| SDISASRPNILLLMA | 31 | P51690 | |
| LQDRLTPMEALLQTR | 1481 | Q9NR09 | |
| SRQMVTDLELSTLLP | 641 | Q6P9F0 | |
| TMRQLGSLQRLNTLS | 46 | Q9NP70 | |
| MQERLLPALQSTITR | 256 | P43353 | |
| QLARALPLNDLMQSV | 1316 | Q7Z2Y8 | |
| SNMDILKPILRTLNS | 231 | O95477 | |
| NDLMKNLESSPLSRI | 356 | O95477 | |
| VLLDLSRTSVLPAQM | 611 | Q8IZP9 | |
| SIANPNSTMILSLVL | 4526 | Q8WXG9 | |
| MSVRLPQSIDRLSSL | 1 | O15085 | |
| PSLSESLMNRNSVLS | 231 | O15085 | |
| EIRTLVDMALTSPLQ | 181 | Q8IY22 | |
| ISPRMEKALSQLALR | 371 | Q9H211 | |
| IMSLISDNAARVLPI | 431 | Q14738 | |
| SALARSLQPSVLMQL | 166 | Q9GZQ3 | |
| TPAQMLLSTLQSTQR | 136 | Q9H2A7 | |
| RLVISPLNQLLSMFT | 1101 | Q6XZF7 | |
| PDLRQTLLMLSIFQQ | 626 | Q17RM4 | |
| AEPDMRLLTVLLQQS | 136 | Q3KP44 | |
| SEMVLALTSCLQPLR | 286 | Q8NEG7 | |
| IQPMALAVRLTANIT | 151 | P00846 | |
| QDMNLSRPLLKAITA | 221 | Q96GQ7 | |
| LLLNLAENPAMTREL | 266 | Q9UH62 | |
| NPLIMLLLASAVISV | 81 | P98194 | |
| VSLMTRALLPLLQQG | 116 | Q9H3Z7 | |
| LTDNIQVPMARASIL | 491 | Q13367 | |
| ETLLQSRVLPSSLML | 121 | Q8N0X4 | |
| NQIALLDSPTALSME | 391 | Q96L93 | |
| QLVSTLVPLLLTMQE | 1126 | Q68CQ1 | |
| SLLMKLFQRSTPAIT | 21 | P00387 | |
| SPTLNRIDMALQTAL | 176 | A0A5F9ZHS7 | |
| RLPALRLMSSNITEE | 546 | P49116 | |
| LQAPIMSLQSVLEDL | 141 | Q4ADV7 | |
| SLLLISGQRPVNLTM | 16 | P0DMC3 | |
| LLRTLVDPENMLATA | 451 | Q6IN85 | |
| RLLLTGTPIQNTMAE | 676 | Q9ULG1 | |
| LPALQLCQVILTSSM | 1621 | Q92621 | |
| LTNLMTRQLLDPTAI | 91 | P47874 | |
| VPTTMLLLTASAQRL | 131 | Q9Y257 | |
| SMLPQSILSDSQICL | 191 | Q8N9N7 | |
| TRLVNPDQLLNEIMS | 566 | Q14680 | |
| LQQGPLLLVAMSRTS | 166 | Q7L1V2 | |
| CTNTLMIQPRLLADA | 151 | Q6WBX8 | |
| LNLLATPRAQLIQMS | 701 | Q96JH8 | |
| SRLLDISVSPLMNSL | 2256 | O14497 | |
| LLSSLLLTMSNNNPE | 21 | Q9UJX3 | |
| SPNSMLRVLLSAQTS | 31 | Q14296 | |
| SITSLLRQLMNLPQS | 651 | Q86TB9 | |
| TDLLTTLSNMLPVRL | 316 | Q96AD5 | |
| MRIEDPSLLNSRVLL | 516 | Q8IY17 | |
| LAAPQLIMLANVALT | 41 | Q13127 | |
| VLDTCTIRMNLNLPA | 321 | M0R2J8 | |
| AIIPRMLADLLSTQR | 76 | Q8NGA6 | |
| AIIPRMLADLLSTQR | 76 | O60403 | |
| NTGVLPRLVVLMTSS | 281 | A9QM74 | |
| PRLVVLMTSSELNVL | 286 | A9QM74 | |
| LMTSSELNVLTPSLR | 291 | A9QM74 | |
| SLSGLQDPIIARMSI | 1631 | Q9ULH0 | |
| QVSLMLQNSSARALP | 806 | Q15746 | |
| MTLQPLRVQLSSGVV | 1961 | Q86XX4 | |
| LQTQTFMQPLTLRRL | 361 | Q92619 | |
| ALASMSLNTQPILNL | 431 | Q8WXG6 | |
| LSSLESILAPQRLMI | 1866 | Q5T1H1 | |
| ASAIQPISEEMQLLL | 426 | Q4ZG55 | |
| TRLLQQSQDPLLMGL | 556 | Q96H55 | |
| LNSGMLALTQTALRL | 1806 | O95714 | |
| LLNPSSDVSERLQMF | 171 | P52732 | |
| TTMLTNILLRTCPQD | 341 | Q9Y234 | |
| ALNISSMSLLAPLAQ | 601 | Q9NQW6 | |
| LSMLNDFVTRTPNLE | 1806 | Q9Y3R5 | |
| LRIFQNMSPLLELSS | 686 | Q9UI26 | |
| NMSPLLELSSENLRT | 691 | Q9UI26 | |
| RETMLQLILSPLNVF | 851 | Q2LD37 | |
| SSDLSRILQLLQKPM | 841 | Q9H252 | |
| ILREIMSDLTQAIPS | 711 | Q5CZC0 | |
| MLVRLSTLCPSAVLQ | 1126 | Q86VP6 | |
| PLMVQLSLLRAETDR | 1161 | O95382 | |
| ESLSRLMATLSNTNP | 676 | Q7Z406 | |
| SPTLESMAQVLSQRL | 416 | Q96B70 | |
| LMSRQDQSIILLGSS | 486 | Q92614 | |
| PVSRSKLQELRALSM | 2476 | O15018 | |
| LTMEDLLQAAARLQP | 946 | Q13608 | |
| GSILSPNLLTIIEMQ | 171 | P26718 | |
| FLALMQSLDTPETNR | 666 | Q14999 | |
| NSVNVMPSASRVILL | 921 | Q14999 | |
| MPSASRVILLENLTR | 926 | Q14999 | |
| LQQLPALIADLESMT | 101 | Q96EV8 | |
| SPLNQRMTENLLASL | 476 | Q12980 | |
| DVMSLTQVIPLLSNL | 326 | Q6UY01 | |
| TPLMIQSLRSRLDEN | 101 | Q96J66 | |
| AQNLTATLPTVRMIV | 1081 | Q9P265 | |
| PTQLTDALTQRSMFL | 366 | Q9HD67 | |
| TKNALDPMSVLLARS | 461 | P42785 | |
| MLDVPIRLTGSQLSI | 726 | Q9UJF2 | |
| SLLAERLMLQTNLIT | 766 | P50851 | |
| GLLPQTMLITDTTNL | 516 | P20823 | |
| SPLSDASLDLQRMIR | 236 | P10070 | |
| LARLDMTSNRLTTIP | 206 | Q9BTN0 | |
| MNRRPILTIITLEDS | 246 | P04637 | |
| LAFATSSVPQMLINL | 71 | O95371 | |
| LRTLIDPENMLATTN | 441 | Q5MIZ7 | |
| LMRLVLTVRSNLIPS | 111 | P23219 | |
| ILSSMRLPLLDTNSK | 391 | Q8NDA8 | |
| EDLLTSLLQRNMTPQ | 901 | Q8NDA8 | |
| LQSLRLSLPMQETQL | 121 | Q08378 | |
| SMRLPLVSDKNLNAV | 1501 | Q9C091 | |
| MPLALATQNTRIVLA | 806 | P42694 | |
| LLQAANLLTPDMITE | 521 | Q86Y91 | |
| DLTELISNMPSLQLT | 306 | Q06190 | |
| QRPAMRSAINLLLAT | 61 | Q9Y5Y3 | |
| DLSSNQLMRLPQELI | 161 | Q9P2V4 | |
| NAQLLSLISAPSTML | 226 | Q9Y2A7 | |
| LLSLLSLMQLRNVSE | 911 | Q5TIA1 | |
| IQMPATLLLTQLSLL | 1161 | P29475 | |
| MASDLIALNRSLPDV | 86 | Q8IUC8 | |
| NNSPVLSERSLLAMQ | 671 | O43182 | |
| LRTPANMFIINLAVS | 101 | Q9UHM6 | |
| RLLPVINTMLQLSLE | 1731 | A6NKT7 | |
| NQQLSIRVPLRSSML | 256 | Q9H7U1 | |
| LGPSSALNQTLMLLR | 436 | Q9Y2V7 | |
| ALNQTLMLLREVLAS | 441 | Q9Y2V7 | |
| MALSPINIQLLAEDR | 406 | O95876 | |
| LNSVLDDNRLLTMPS | 2066 | Q8NCM8 | |
| RSPVVLQSILSLMDR | 126 | Q9NWS6 | |
| ALNSLSENQSLLRMP | 911 | P16615 | |
| MVRLLPDTINSINLD | 1716 | Q14008 | |
| VLLPATEMASLLSLQ | 66 | Q5TZA2 | |
| MLTLSPSILAELQLR | 366 | O43464 | |
| MENLLDNLNLLSSPT | 371 | Q12778 | |
| AKLSNLPTLISMRLE | 1081 | Q8NF50 | |
| PIMSSADALLDLIRN | 131 | O00341 | |
| ESMERIPSSLDNLLL | 176 | Q9UFH2 | |
| PRDSLNQSLSQDLTM | 176 | P15391 | |
| MLPLLTQDSNSKARR | 171 | Q6ZNG2 | |
| RLSLPRLIDMSAQIA | 331 | P51451 | |
| LILVSALSQLMVSSP | 256 | Q9NXW2 | |
| RTILMQSSLPQAQLA | 246 | Q15811 | |
| PTSDTNLVRSLMNLI | 1806 | Q8WXX0 | |
| LRAQDPSEVLTMLTN | 146 | Q12905 | |
| FLRSMTALLDPAQIE | 441 | A2RUB6 | |
| MTPQSLLQTTLFLLS | 1 | Q9Y653 | |
| PNRMALSAVSELILS | 221 | Q86UW7 | |
| SSVNLLMANLESLPV | 311 | Q86UW7 | |
| PLLIMTDASLVDLNT | 211 | Q969Z3 | |
| VRSMLDLRQLETLAP | 866 | O60336 | |
| QPPTTVLSLLRQSQM | 661 | Q9P267 | |
| SQELRQLVGLLSPMV | 271 | Q15051 | |
| RMILLSTPSQSDALR | 21 | O43812 | |
| LRGNALATLTQMRLS | 651 | P57679 | |
| LQQPVRLLSASMDKT | 301 | Q6IA86 | |
| SQDPQMRLKLFSILS | 616 | Q86Y56 | |
| SRKLDNNRPLVASML | 1231 | Q9NYQ7 | |
| QQRLVALTFIPSIMS | 66 | Q9Y267 | |
| NESTLPQLAAMIITL | 201 | Q504Y0 | |
| NVLSMAQLRTLPLAD | 266 | Q9NVU0 | |
| LMLLSLRSTEGIVPQ | 611 | Q8TEX9 | |
| MKQLPAATVRLLSSS | 1 | P54277 | |
| LETSSALQLLMPTLE | 381 | Q5VV67 | |
| SENRFTTSLLMIPLL | 651 | P10243 | |
| LQEVLTLLPNSMALL | 1726 | Q5VW36 | |
| RNVLSLLPETLIGNM | 561 | O15259 | |
| QVSQRLATDLLSLMP | 311 | Q969Z0 | |
| LMLQNLSSLRSVSLA | 151 | Q86YC3 | |
| QALSISAMEELPRVL | 21 | Q5VWM6 | |
| LQLASAIVTLTPMEQ | 1026 | Q5VU65 | |
| EVNRALDMSLPSLVL | 1946 | Q12923 | |
| LDMSLPSLVLKATRN | 1951 | Q12923 | |
| AIIPRMLADLLSTQR | 76 | Q9Y4A9 | |
| RESLLPVINTMLQLS | 1711 | P0DJD0 | |
| VSARTAPQDSMLVLL | 1981 | Q6ZRI0 | |
| PQVLQRNSSTMDLTL | 386 | Q9BUB5 | |
| SLIQMTILNLLPRLA | 386 | P42345 | |
| GIAMLNLLRTLSQSI | 596 | A6NES4 | |
| NLLRTLSQSIAPSMA | 601 | A6NES4 | |
| LNILPMVISSIVQAS | 596 | P33527 | |
| PVMRVSLSQQSSLLT | 911 | Q86VV8 | |
| AMCSLLDNLLTIAPR | 1616 | Q86VV8 | |
| NLTVAMLANLIPFTL | 176 | P59543 | |
| ISKMNQLLSRTPALS | 411 | Q92777 | |
| ESPFAMAQIQSLSLR | 626 | Q8NBS3 | |
| LRLPQLVDMAAQIAS | 361 | P12931 | |
| QMATAPDSQRLKLLR | 146 | Q9UQE7 | |
| LENLRQSLSLPSMLR | 356 | Q96R06 | |
| TLQNAGVMSLLRTLL | 36 | O75602 | |
| MIRLDEVPNLSSLVS | 221 | Q8TEL6 | |
| MNPLETLSITNCRLS | 321 | P78395 | |
| SVLNIEMNFILSPSL | 491 | Q9BXR5 | |
| MAVTEASLLRQCPLL | 1 | Q9NW38 | |
| LLPLQSALSAVSSMR | 1751 | O14513 | |
| QALSISAMEELPRVL | 21 | Q5SWL7 | |
| LPSKDVQSLSLRIML | 116 | Q9H3E2 | |
| LTLVVSPLLSLMDDQ | 526 | O94761 | |
| FMSSSLLIDIQPNTL | 431 | Q8N3V7 | |
| RSTEELVPSIMSNLL | 66 | Q86UY8 | |
| EPNMDLINLLTLSLD | 351 | Q8IV61 | |
| LRAEALQSTFLLMSP | 311 | Q9Y6C5 | |
| DVQPSKLMRLLSSNE | 851 | O75448 | |
| ITVSDLNQPMLVSLL | 346 | Q7Z3Z4 | |
| LQSRLTTPMLQSLLG | 306 | Q9Y4R8 | |
| SLLLMTRNDVLTGLQ | 81 | Q5VXD3 | |
| NSMSARVLLLLVVPG | 371 | Q96GZ6 | |
| QALSISAMEELPRVL | 21 | O95521 | |
| RLLSMGQLDLLRSNT | 56 | Q9H1D9 | |
| LINQMLSLNRTPSEI | 96 | G3V0H7 | |
| LTELMFDNALSTLRP | 1091 | Q15477 | |
| QALSISAMEELPRVL | 21 | O60811 | |
| SLIMLRNPVTSTNVL | 306 | Q96K37 | |
| LFDQEPMRSLVLSQS | 466 | Q9C0C4 | |
| RILRLPASQDMLALQ | 336 | A4QPH2 | |
| MSIQDSLALQPKLTR | 211 | Q86SQ0 | |
| ALLQEMPLTALLRNL | 271 | P10155 | |
| MRQRLLPSVTSLLLV | 1 | Q08648 | |
| QLRAMLPVLQGTSVT | 1016 | Q7RTU9 | |
| LLTRLALMDPTSLNQ | 1036 | Q9NRP7 | |
| DSLPAMRQLLAAFTI | 336 | Q9NRC6 | |
| SLLLQAQSLLPRTMA | 586 | Q9BX79 | |
| LSNITIRIPRGQLTM | 696 | Q09428 | |
| ADRIITMLPTSINAI | 96 | P31937 | |
| NTLLMDFLSPTLQVA | 16 | Q5TBC7 | |
| SLQSLPRFILLELMA | 1186 | Q9UM73 | |
| DTRPLILMSLGNELI | 436 | Q96M20 | |
| QLSNMLPQIFRVSST | 531 | Q9NQ89 | |
| QASKLTPSMLRLAIE | 171 | Q5SYC1 | |
| MNIARALQLSPSLRT | 241 | Q9BXT8 | |
| NIRLSELLSNPNMLT | 191 | Q8NEY3 | |
| ATSLLPLTEANLRMF | 81 | Q9NUL5 | |
| PTVERSRLQEMLSLL | 66 | Q8TCY9 | |
| LTSTLNMLIPSAARV | 161 | Q9P2U8 | |
| PLTDNTRMLASILIN | 346 | Q8IWX7 | |
| CRRTLMEQPLTTLNI | 226 | Q9P2K2 | |
| LTLRDMSLSQPTIAA | 1551 | Q8IZQ1 | |
| MSLSQPTIAAISNVL | 1556 | Q8IZQ1 | |
| EASRITLLLMASQEP | 1376 | P04275 | |
| ENMTSGPSLALVLLR | 376 | Q8N427 | |
| LSNLVMEELLPTLQT | 241 | Q9BZQ8 | |
| LRVLPDTMRNLLSTQ | 486 | Q9ULX5 | |
| TDPAISMDLLRAVLQ | 61 | Q9H147 | |
| SMDLLRAVLQPSINE | 66 | Q9H147 | |
| SLESLNQMILELDPT | 101 | Q8IZW8 | |
| PDLRLLLVAEMNSSL | 206 | A6NE52 | |
| VLLRLLPNMSSDLQG | 1231 | A6NE52 | |
| AQKQNEMLLLSRSPS | 736 | Q5VZP5 | |
| LLLRTNLMKTQTLPT | 801 | Q96DN2 | |
| LQTALSLISMTSPRN | 996 | Q6ZS81 | |
| LRNQLLEMLLSVISS | 1591 | Q6ZS81 | |
| MASILRSPQALQLTL | 1 | O75414 | |
| TISRLLQMPLFSDVL | 386 | Q7Z7A4 | |
| VMSTLLPSLREKAQN | 316 | Q96LQ0 | |
| SSILLALQVMLSNPV | 106 | Q5VVX9 | |
| MKRLSLVTTNRLSPQ | 1 | O75679 | |
| TRLIDLPGTELAQLM | 66 | Q14CB8 | |
| LVLSMLIRNNFLPNT | 1126 | O00507 | |
| AQTLRAMLLSFPDVL | 176 | Q7Z5H5 | |
| PLSMQRIASLLTLLT | 716 | Q9BWH6 | |
| LLAALTMDNRLTIQA | 181 | Q9UKN8 | |
| LQMITVLIRSLTTDP | 246 | Q8NB14 | |
| SEQSSMLELLRQRLP | 781 | Q5VIR6 | |
| LTPDNVANLVLISMV | 406 | Q92797 | |
| NLRMPLTLTSNTQVI | 486 | Q9HC78 | |
| LVLATQMSRPTICQL | 171 | Q9BZF9 | |
| TVMVPQLRRENSLLL | 251 | Q6PJI9 | |
| TQLALAIADLALQMP | 106 | Q9Y5L0 | |
| REASKMALLPSLQSN | 1046 | O15090 | |
| MLQQLLITLPTEAST | 1 | Q9UJL9 | |
| LVMLADSSPSNLQII | 1641 | Q9UPU5 | |
| LMPDISQSVLDASLL | 3166 | Q7Z7G8 | |
| QLRAMLPVLQGTSVT | 1016 | A6NGW2 | |
| SKSIMRQRLISPQLS | 271 | P57082 | |
| DNLSLALPVTAAMLN | 241 | Q2TBF2 | |
| LDAQLRRTLSPEMIT | 1796 | Q9H4A3 | |
| AIQIASATMPALSLN | 601 | Q9BXT5 | |
| TLSLDVPTNIMNLLF | 121 | Q969E3 | |
| LSSLQPRLNSIMQAS | 226 | Q13769 | |
| MRQRLLPSVTSLLLV | 1 | Q6PDA7 | |
| LLLMVSQLRAVSFPE | 11 | Q8NFY4 | |
| DSVPLMNLLLTLLST | 526 | Q5T4S7 | |
| MQRLPAATRATLILS | 1 | A2RRL7 | |
| SLSILTNPRAMQALL | 456 | Q9NRR5 | |
| DLASPTALLIMRTVL | 1186 | Q69YN4 | |
| TTLQPRLFTMDLNVV | 1316 | Q9Y4A5 | |
| AMLPSITNVINLADS | 2516 | Q9Y4A5 | |
| VSLQPVLDTLLQMSG | 816 | Q562E7 | |
| DQLAPTRSTSLLNSM | 651 | Q6PFW1 | |
| SAPMVDNELLRLSLR | 1621 | Q5T200 | |
| VQITPETMNGLRLAL | 1346 | Q7Z3T8 | |
| EITLLMQTLNTLSTP | 171 | P40222 | |
| LATSLPRLMNSQDDQ | 381 | O43156 | |
| VMLRNSDANLLPLVA | 721 | O43156 | |
| QVELRLPISETLSQM | 181 | Q9H7M6 | |
| LPISETLSQMNRDQL | 186 | Q9H7M6 | |
| LLPMLLELETVRNTA | 876 | Q8N5Q1 | |
| QVLMTQSRVLSSPQL | 3826 | O14686 | |
| MPQFLSTEAQSLLRA | 281 | Q15418 | |
| PVVLNLLSSRQVMNT | 381 | Q96S06 | |
| CPMTQSLQIARDRLL | 126 | Q8N1T3 | |
| LQELGILSLTPARMV | 681 | O75113 |